Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
44816808	li-cxcl13	— (—)	1328	1419	100.00%	Distribution not available
44816808	li-cxcl13	ng/l (ng/l)	391	428	5.37%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Lyme disease

352

288

12.60

307.65

1.1

1178.69

564.61

ng/l

0.61

Other spirochaetal diseases

352

294

12.33

307.65

1.1

1178.69

564.61

ng/l

0.61

Spirochaetal infections, other/unspecified

285

42.84

307.65

1.1

1356.69

573.75

ng/l

0.71

Inflammatory diseases of the central nervous system

192

21.83

256.35

1.2

1.1

364.03

326.17

ng/l

0.07

101

Neurological diseases

453

387

5.93

185.49

1.1

300.07

716.56

ng/l

0.63

Symptoms and signs involving the nervous and musculoskeletal systems

380

806

4.76

165.51

1.1

156.50

710.21

ng/l

1.55

206

Encephalitis

36.65

153.96

1.3

1.0

306.83

29.00

ng/l

—

Viral infections of the central nervous system

131

16.08

152.02

1.2

1.1

96.94

324.18

ng/l

0.82

Headache

373

677

4.64

148.69

1.1

95.47

707.43

ng/l

1.81

164

Polyneuropathies and other disorders of the peripheral nervous system

202

257

8.02

148.32

1.1

546.98

530.20

ng/l

0.02

Meningitis

106

18.94

132.89

1.2

1.1

539.12

37.67

ng/l

—

Other and unspecified polyneuropathies, also in other diseases

175

218

8.19

130.83

1.1

601.20

579.00

ng/l

0.02

Other symptoms and signs involving the nervous and musculoskeletal systems

278

574

4.89

125.31

1.2

1.1

51.30

526.59

ng/l

1.88

142

Symptoms and signs involving cognition, perception, emotional state and behaviour

497

1023

3.42

124.80

1.1

365.92

608.63

ng/l

0.55

262

Other symptoms and signs involving cognitive functions and awareness

248

462

5.08

114.46

1.1

407.12

545.69

ng/l

0.19

117

Abnormal findings on diagnostic imaging of central nervous system

18.65

108.40

1.1

542.35

408.11

ng/l

—

General symptoms and signs

506

775

3.29

106.22

1.1

446.33

659.65

ng/l

0.32

108

185

Bell's palsy

123

133

9.46

102.96

1.1

882.03

273.44

ng/l

0.65

Neurological diseases, wide definition

176

9.56

101.31

1.1

215.05

1067.36

ng/l

0.49

Other degenerative diseases of the nervous system

142

122

8.90

99.61

1.2

1.1

106.47

170.38

ng/l

0.25

Certain infectious and parasitic diseases

433

648

3.36

93.99

1.1

498.18

130.31

ng/l

1.11

112

Disturbances of skin sensation

195

386

5.11

92.56

1.1

731.67

315.69

ng/l

0.26

Epilepsy

189

374

5.09

89.30

1.1

126.76

634.80

ng/l

1.09

Fever of other and unknown origin

245

584

3.91

81.51

1.1

507.58

754.04

ng/l

0.28

147

Convulsions, not elsewhere classified

139

231

6.00

78.29

1.1

86.92

210.40

ng/l

0.91

Nerve, nerve root and plexus disorders

463

1078

2.71

76.45

1.1

473.74

591.61

ng/l

0.19

105

244

Other meningitis

32.06

75.98

1.2

1.1

275.00

—

ng/l

—

Status epilepticus

22.85

75.00

1.2

1.0

75.50

304.20

ng/l

—

Visual disturbances and blindness

252

716

3.54

74.17

1.1

1137.25

450.48

ng/l

0.66

171

Malaise and fatigue

216

447

4.05

72.99

1.1

251.62

643.74

ng/l

0.56

111

Demyelinating diseases of the central nervous system

108

8.42

68.13

1.1

117.47

465.80

ng/l

0.78

Intracranial trauma

186

318

4.39

67.14

1.1

108.70

600.42

ng/l

0.84

Visual disturbances

229

673

3.43

64.07

1.1

1179.63

255.75

ng/l

0.98

160

Concussion

159

306

4.51

62.63

1.1

104.07

555.64

ng/l

0.74

Medical observation and evaluation for suspected diseases and conditions

309

505

3.15

61.62

1.1

457.04

519.24

ng/l

0.09

135

Other neurological diseases

305

876

2.81

57.97

1.1

149.99

753.53

ng/l

1.98

213

Dizziness and giddiness

293

835

2.86

57.59

1.1

385.88

656.72

ng/l

0.49

221

Symptoms and signs involving the skin and subcutaneous tissue

297

1079

2.75

56.99

1.1

726.81

539.10

ng/l

0.17

261

Migraine

219

562

3.33

56.35

1.1

156.55

335.91

ng/l

0.51

133

Episodal and paroxysmal disorders

442

930

2.44

56.24

1.1

299.07

516.12

ng/l

0.72

221

Focal epilepsy

130

283

4.64

55.26

1.2

1.1

97.97

393.97

ng/l

1.54

Postprocedural disorders of nervous system

8.58

53.73

1.1

31.32

344.60

ng/l

—

Focal epilepsy, strict definition

123

265

4.69

53.00

1.2

1.1

104.32

421.83

ng/l

1.53

Condition for Implicit Sepsis (Organ dysfunction codes)

343

982

2.55

52.56

1.1

689.82

548.41

ng/l

0.13

247

Other demyelinating diseases of the central nervous system

13.67

52.12

1.2

1.1

210.43

552.83

ng/l

—

Viral meningitis

14.37

50.36

1.2

1.1

127.65

221.00

ng/l

—

Other soft tissue disorders, not elsewhere classified

369

951

2.41

48.13

1.1

223.70

533.43

ng/l

1.22

231

MS-disease / Multiple Sclerosis

7.91

48.12

1.2

1.0

37.46

425.58

ng/l

0.81

Focal epilepsy, mode (most common among epilepsy diagnosis)

114

253

4.55

47.41

1.1

96.88

434.51

ng/l

1.61

Pain, not elsewhere classified

116

266

4.39

46.24

1.1

1120.44

279.00

ng/l

0.42

Dorsalgia

382

890

2.33

44.93

1.1

822.16

454.23

ng/l

0.54

222

Diplopia

144

5.77

44.61

1.2

1.1

2464.42

247.55

ng/l

1.15

Myalgia

115

270

4.29

44.52

1.1

105.21

593.83

ng/l

0.93

Cerebrovascular diseases (FINNGEN)

171

362

3.40

43.25

1.1

530.37

341.23

ng/l

0.22

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

133

146

4.58

42.95

1.1

221.14

420.90

ng/l

0.58

Infections, IBD-co-morbidities

9.12

42.77

1.1

375.40

1348.31

ng/l

0.33

Abnormalities of gait and mobility

127

5.91

41.26

1.1

563.92

416.17

ng/l

0.10

Speech disturbances, not elsewhere classified

6.81

39.05

1.2

1.1

197.62

451.76

ng/l

0.39

Disorders of optic nerve and visual pathways

117

5.99

38.98

1.2

1.1

101.16

249.44

ng/l

0.56

Other dorsopathies, not elsewhere classified

367

898

2.16

36.15

1.1

764.20

452.20

ng/l

0.43

223

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

235

895

2.44

35.14

1.1

353.30

694.52

ng/l

0.66

214

Implicit Sepsis

269

906

2.32

34.42

1.1

785.17

592.09

ng/l

0.16

225

Low back pain

259

851

2.35

34.24

1.1

606.46

467.66

ng/l

0.19

215

Bacterial infection, other or unspecified

196

674

2.63

34.09

1.1

814.92

527.37

ng/l

0.30

146

Pain in joint

207

516

2.66

34.09

1.1

289.97

714.90

ng/l

0.69

140

Pain (limb, back, neck, head abdominally)

265

545

2.44

33.79

1.1

438.08

694.46

ng/l

0.34

144

Pain in limb

282

905

2.26

33.58

1.1

288.21

550.43

ng/l

0.75

223

Other headache syndromes

154

536

2.89

32.64

1.1

101.81

374.01

ng/l

0.99

138

GASTRO-related operations

300

666

2.27

32.59

1.1

264.86

267.46

ng/l

0.01

129

Any gastric operation

300

666

2.27

32.59

1.1

264.86

267.46

ng/l

0.01

129

STROKE

234

681

2.39

31.40

1.1

691.76

693.89

ng/l

0.00

159

Autoimmune diseases excluding thyroid diseases

373

1033

2.01

30.99

1.1

321.82

500.74

ng/l

0.42

105

207

Cerebrovascular diseases

260

827

2.26

30.93

1.1

711.30

669.73

ng/l

0.04

199

Autoimmune diseases excluding thyroid diseases, strict definition

363

1006

2.02

30.47

1.1

331.66

508.48

ng/l

0.40

101

202

Migraine without aura

217

3.99

30.37

1.1

59.45

477.84

ng/l

0.57

Migraine with aura

264

3.66

29.99

1.1

142.84

474.81

ng/l

0.49

Disorders of thyroid, IBD co-morbidities

6.70

29.99

1.1

884.85

1359.31

ng/l

0.13

Viral Sepsis

239

3.80

29.62

1.2

1.1

154.29

351.57

ng/l

0.64

Lower back pain or/and sciatica

353

1245

1.97

29.42

1.1

419.04

571.64

ng/l

0.31

299

Dorsopathies

356

905

2.01

29.10

1.1

704.07

450.25

ng/l

0.34

224

Other disorders of optic [2nd] nerve and visual pathways

6.68

28.95

1.2

1.1

69.39

297.42

ng/l

0.73

ILD medications: prednisolone, methylprednisolone, prednisone

378

1101

1.94

28.87

1.1

545.16

603.60

ng/l

0.08

231

Implicit viral Sepsis

239

3.75

28.84

1.2

1.1

154.29

351.57

ng/l

0.64

Subjective visual disturbances

104

311

3.37

28.64

1.1

71.80

368.91

ng/l

2.03

ILD medications

390

1126

1.91

27.91

1.1

447.96

596.55

ng/l

0.24

234

Autoimmune diseases related-to ILD

295

1306

1.99

26.61

1.1

256.63

613.24

ng/l

1.08

276

Systemic connective tissue disorders

135

492

2.76

26.39

1.1

242.62

478.16

ng/l

0.52

112

Syncope and collapse

134

426

2.80

26.22

1.1

1000.08

809.90

ng/l

0.08

104

Cerebral palsy and other paralytic syndromes

141

4.51

26.11

1.1

121.33

445.93

ng/l

0.84

Optic neuritis

8.10

26.06

1.2

1.1

133.42

62.71

ng/l

—

General examination and investigation of persons without complaint and reported diagnosis

220

505

2.33

25.91

1.1

423.52

519.24

ng/l

0.11

135

Cerebral cysts

6.66

25.13

1.1

96.17

333.88

ng/l

—

Soft tissue disorders

354

968

1.90

24.99

1.1

416.30

531.37

ng/l

0.17

232

Small fibre neuropathy

10.28

24.81

1.2

1.1

37.22

510.71

ng/l

—

Abnormal involuntary movements

143

4.37

24.75

1.1

63.29

248.55

ng/l

—

Diseases of the eye and adnexa

298

739

2.02

24.73

1.1

280.72

309.23

ng/l

0.07

158

First line medication for Crohn's disease

372

1097

1.85

24.56

1.1

749.35

472.12

ng/l

0.37

226

Stroke, including SAH

207

685

2.24

24.54

1.2

1.1

681.91

789.70

ng/l

0.09

164

Oral corticosteroids

356

1159

1.86

24.46

1.1

518.26

593.45

ng/l

0.10

251

Stroke, excluding SAH

193

628

2.29

24.06

1.2

1.1

711.56

678.83

ng/l

0.02

155

Enlarged lymph nodes

151

4.20

23.92

1.1

646.29

281.79

ng/l

0.43

Examination and observation for other reasons

192

502

2.33

23.70

1.1

619.30

526.30

ng/l

0.11

133

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

6.40

23.57

1.2

1.1

1096.85

120.93

ng/l

0.74

Visual impairment including blindness (binocular or monocular)

6.52

23.46

1.1

438.71

84.74

ng/l

—

Paralytic strabismus

5.59

22.74

1.1

1165.69

332.68

ng/l

—

Opioids

331

928

1.88

22.53

1.1

228.04

604.19

ng/l

1.06

221

Used for control exclusion in common control thyroid runs

348

958

1.85

22.30

1.1

452.54

495.26

ng/l

0.06

191

Other bacterial diseases

305

1127

1.88

22.11

1.1

725.51

538.24

ng/l

0.24

244

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

5.30

22.01

1.1

1019.64

132.89

ng/l

0.72

Nausea and vomiting

321

2.99

21.95

1.1

426.75

263.91

ng/l

0.17

Cervicalgia

231

3.40

21.91

1.1

1416.18

606.18

ng/l

0.24

Diagnoses used for exclusion with ILD

101

349

2.91

21.90

1.2

1.1

344.65

451.86

ng/l

0.13

Implicit bacterial Sepsis

128

455

2.59

21.83

1.1

1278.21

468.57

ng/l

0.54

123

Diseases of the myoneural junction and muscle

145

4.11

21.73

1.2

1.1

547.86

244.66

ng/l

0.29

Symptoms and signs involving speech and voice

121

462

2.63

21.70

1.1

175.29

677.05

ng/l

1.25

110

Dysphagia

294

3.08

21.54

1.2

1.1

622.33

758.59

ng/l

0.09

Ischaemic Stroke, excluding all haemorrhages

174

580

2.28

21.50

1.2

1.1

377.21

793.93

ng/l

0.55

150

Inflammatory bowel disease treatment related agents

374

1205

1.77

21.46

1.1

467.63

579.77

ng/l

0.17

258

Other antidepressants

341

975

1.83

21.43

1.1

694.25

459.58

ng/l

0.34

233

ILD medications: immunosuppressive drugs

209

973

2.07

21.31

1.1

319.25

678.65

ng/l

0.76

202

Other systemic involvement of connective tissue (FG)

320

2.96

21.28

1.1

63.43

1061.32

ng/l

1.21

Other necrotizing vasculopathies (FG)

6.33

21.02

1.1

247.42

615.13

ng/l

0.37

Sciatica+with lumbago

162

680

2.27

20.88

1.1

327.25

508.18

ng/l

0.22

179

Malignant neoplasm of brain

7.47

20.84

1.2

1.1

1286.00

533.66

ng/l

—

Radiculopathy

183

3.63

20.52

1.1

873.33

284.50

ng/l

0.34

Spondylopathies

242

739

1.99

20.40

1.1

1027.35

486.71

ng/l

0.57

193

Delirium, not induced by alcohol and other psychoactive substances

115

4.38

20.05

1.1

514.57

296.89

ng/l

—

Anxiety disorders, excluding more controls

272

962

1.88

19.74

1.1

130.52

457.58

ng/l

1.70

233

Bacterial Sepsis

140

528

2.37

19.67

1.2

1.1

1078.37

548.57

ng/l

0.38

135

Other intervertebral disc disorders

252

800

1.93

19.53

1.1

392.21

490.37

ng/l

0.13

203

Symptoms and signs involving the digestive system and abdomen

333

936

1.79

19.29

1.1

309.12

675.99

ng/l

0.86

215

Temporomandibular joint disorders

146

3.86

19.04

1.1

108.89

745.60

ng/l

—

Autoimmune diseases

353

1039

1.74

18.78

1.1

387.89

498.34

ng/l

0.20

208

Persons encountering health services for examination and investigation

209

505

2.08

18.77

1.1

450.86

519.24

ng/l

0.09

135

Other specific joint derangements/joint disorders

247

878

1.89

18.35

1.1

250.40

452.84

ng/l

0.63

213

Codeine

300

917

1.80

18.32

1.1

507.83

607.46

ng/l

0.10

219

Organic, including symptomatic, mental disorders

142

452

2.27

17.47

1.1

574.37

363.32

ng/l

0.23

122

Cardiovascular diseases

220

612

1.96

17.38

1.1

233.98

264.48

ng/l

0.10

130

Other disorders of eye and adnexa

185

3.38

17.32

1.2

1.1

350.44

435.63

ng/l

0.11

Certain disorders involving the immune mechanism

284

2.87

17.22

1.1

690.55

355.98

ng/l

0.32

Somatoform disorder

201

3.25

17.15

1.1

67.45

424.46

ng/l

1.30

Other special examinations and investigations of persons without complaint or reported diagnosis

202

505

2.03

17.12

1.1

754.96

519.24

ng/l

0.29

135

Persons encountering health services for specific procedures and health care

340

1253

1.68

16.95

1.1

178.25

655.53

ng/l

2.04

275

Neurotic, stress-related and somatoform disorders

285

1160

1.75

16.78

1.1

136.94

604.75

ng/l

1.91

265

Other systemic involvement of connective tissue

373

2.59

16.74

1.1

63.43

591.13

ng/l

1.32

Anxiety disorders

287

1169

1.74

16.67

1.1

134.31

606.26

ng/l

1.96

266

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

166

3.46

16.55

1.2

1.1

1811.40

486.67

ng/l

0.93

Tramadol

241

842

1.84

16.51

1.1

602.74

648.40

ng/l

0.04

204

Other disorders of lacrimal gland

115

490

2.36

16.46

1.1

1396.01

422.74

ng/l

0.57

118

Sarcoidosis

190

3.24

15.95

1.2

1.1

547.83

442.32

ng/l

0.07

Migraine without aura and triptan purchases

212

3.08

15.73

1.1

63.30

393.32

ng/l

—

Other necrotizing vasculopathies

4.66

15.64

1.1

247.31

573.63

ng/l

0.39

Primary_lymphoid and hematopoietic malignant neoplasms

305

2.70

15.62

1.2

1.1

1602.21

385.79

ng/l

1.04

Symptoms and signs involving the urinary system

232

995

1.81

15.48

1.1

697.62

581.23

ng/l

0.11

249

Non-follicular lymphoma

113

3.93

15.37

1.2

1.1

2092.43

433.42

ng/l

0.88

Parasetamol

260

744

1.79

15.30

1.1

265.07

485.48

ng/l

0.60

165

Diseases of the musculoskeletal system and connective tissue

179

443

2.03

15.27

1.1

220.70

372.16

ng/l

0.30

112

Non-follicular lymphoma, hilmo, excluding all cancers

114

3.89

15.19

1.2

1.1

2092.43

172.73

ng/l

1.10

Cervicobrachial syndrome

265

2.80

15.17

1.1

135.64

552.55

ng/l

0.74

Trigeminal neuralgia

5.32

15.14

1.1

1123.50

92.07

ng/l

—

Oedema, not elsewhere classified

287

2.71

15.01

1.1

23.50

278.75

ng/l

1.60

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

295

1264

1.68

14.96

1.1

839.70

465.82

ng/l

0.47

281

Primary_lymphoid and hematopoietic malignant neoplasms

313

2.63

14.88

1.2

1.1

1602.21

445.62

ng/l

0.96

Disorders of ocular muscles, binocular movement, accommodation and refraction

152

752

2.01

14.66

1.1

786.82

380.78

ng/l

0.44

170

Malignant neoplasm of eye, brain and central nervous system

5.16

14.60

1.2

1.1

1286.00

385.30

ng/l

0.52

Abdominal and pelvic pain

311

935

1.67

14.60

1.1

287.13

675.99

ng/l

0.90

215

COPD differential diagnosis

251

707

1.78

14.58

1.1

432.12

603.27

ng/l

0.24

160

Codeine or tramadol medication

346

1187

1.62

14.52

1.1

442.04

579.06

ng/l

0.18

280

Gastro-oesophageal reflux disease

211

1036

1.81

14.52

1.1

451.54

638.63

ng/l

0.28

250

Ocular pain

100

4.04

14.51

1.2

1.1

529.45

533.20

ng/l

0.00

Exclusions for E4_PCOS_BROAD

255

2.80

14.49

1.1

724.24

312.62

ng/l

0.55

Other diseases of spinal cord

6.99

14.45

1.2

1.1

106.67

233.86

ng/l

—

Cervical disc disorders

113

509

2.23

14.26

1.1

665.24

575.76

ng/l

0.08

144

Finngen Rheumatological endpoints

303

1043

1.66

14.15

1.1

181.63

596.23

ng/l

1.48

244

ILD differential diagnosis

249

707

1.77

14.11

1.1

432.12

603.27

ng/l

0.24

160

Mood disorders, excluding more controls

284

1032

1.68

14.03

1.1

967.49

465.47

ng/l

0.28

251

Other/unspecified dorsalgia

107

472

2.26

14.02

1.1

785.33

339.41

ng/l

0.42

129

Intracranial injury

172

878

1.90

14.00

1.1

92.60

633.28

ng/l

2.73

200

Other disorders of urethra and urinary system

206

854

1.81

13.86

1.1

713.27

344.40

ng/l

0.26

200

Extrapyramidal and movement disorders

109

490

2.23

13.84

1.1

2251.35

468.37

ng/l

0.40

120

Excluding asthma or asthma-COPD overlap

249

712

1.75

13.80

1.1

415.08

603.69

ng/l

0.27

160

Pneumonitis due to solids and liquids

4.39

13.79

1.2

1.1

67.67

264.66

ng/l

0.68

Second line medication for Crohn's disease

176

946

1.87

13.67

1.2

1.1

342.95

669.00

ng/l

0.67

216

Symptoms and signs involving the circulatory and respiratory systems

320

986

1.63

13.57

1.1

282.00

358.25

ng/l

0.18

228

Other reaction to severe stress, and adjustment disorders

119

561

2.13

13.44

1.1

263.16

416.95

ng/l

0.27

125

Other and unspecified visual disturbances

3.95

13.41

1.1

110.17

320.89

ng/l

—

Strabismus

408

2.33

13.40

1.1

650.01

241.34

ng/l

0.48

Disorders of lacrimal system

128

622

2.06

13.35

1.1

1211.55

616.74

ng/l

0.35

151

Abnormalities of breathing

275

980

1.67

13.34

1.1

665.18

359.74

ng/l

0.50

227

Hypertensive diseases (excluding secondary)

183

564

1.89

13.33

1.1

361.68

337.65

ng/l

0.04

135

Psychiatric diseases

328

1024

1.61

13.16

1.1

598.85

451.94

ng/l

0.19

252

Other pulmonary diagnosis

246

712

1.73

13.11

1.1

490.44

603.69

ng/l

0.15

160

Depression medications

102

214

2.40

12.99

1.1

70.00

264.51

ng/l

0.87

Coxibs

203

2.47

12.89

1.1

239.68

843.22

ng/l

0.77

Cardiovascular diseases (excluding rheumatic etc)

216

705

1.77

12.87

1.1

170.21

303.07

ng/l

0.75

152

Pain in throat and chest

257

939

1.68

12.72

1.1

867.42

367.41

ng/l

0.42

222

Other viral diseases

102

462

2.21

12.68

1.1

89.13

247.89

ng/l

1.10

102

Anaemias

204

2.58

12.63

1.1

132.76

264.51

ng/l

0.48

Diseases of oesophagus, stomach and duodenum

316

1212

1.59

12.59

1.1

327.78

612.80

ng/l

0.69

280

Benzodiazepine use

292

1301

1.60

12.43

1.1

1462.93

424.82

ng/l

0.58

315

Other diseases of intestines

320

1180

1.58

12.40

1.1

242.87

495.97

ng/l

1.01

268

Oxycodone

104

466

2.17

12.25

1.1

794.44

601.08

ng/l

0.15

118

Asthma (mode)

223

707

1.74

12.24

1.1

214.16

603.27

ng/l

0.77

160

Spondylosis

147

658

1.92

12.23

1.1

530.54

524.92

ng/l

0.01

173

L04AX Other immunosuppressants

168

925

1.82

12.15

1.2

1.1

375.37

657.11

ng/l

0.51

211

Diffuse large B-cell lymphoma, helper endpoint

5.07

11.96

1.2

1.1

2930.77

53.99

ng/l

0.99

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

5.07

11.96

1.2

1.1

2930.77

53.99

ng/l

0.99

Other and unspecified myopathies

101

3.69

11.93

1.1

629.08

241.00

ng/l

0.33

Disorders of eyelid, lacrimal system and orbit

240

1140

1.65

11.91

1.1

745.38

518.05

ng/l

0.25

274

Depression or dysthymia

205

655

1.75

11.76

1.0

1.1

2589.53

529.46

ng/l

0.72

176

Diffuse large B-cell lymphoma

4.97

11.70

1.2

1.1

2930.77

268.24

ng/l

0.89

Asthma, excluding more controls

220

683

1.72

11.65

1.1

224.48

618.97

ng/l

0.74

155

Hypo-osmolality and hyponatraemia

194

2.84

11.63

1.1

805.56

311.04

ng/l

0.70

Chronic laryngitis and laryngotracheitis

179

2.92

11.57

1.1

1182.36

326.51

ng/l

—

Metabolic disorders

277

1077

1.60

11.55

1.1

574.63

593.95

ng/l

0.02

235

Traumatic subdural haemorrhage

4.66

11.35

1.1

1.0

77.00

249.00

ng/l

—

Influenza and pneumonia

310

1325

1.54

11.13

1.1

637.55

523.39

ng/l

0.16

286

Provisional assignment of new diseases of uncertain etiology

133

701

1.90

11.09

1.1

117.93

480.30

ng/l

1.48

168

Asthma

221

702

1.69

11.08

1.1

224.48

607.06

ng/l

0.73

159

Codes for special purposes

133

702

1.90

11.04

1.1

117.93

480.30

ng/l

1.48

168

Sixth [abducent] nerve palsy

5.80

11.03

1.1

772.60

115.50

ng/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

241

2.58

10.97

1.0

1.1

238.25

291.70

ng/l

0.16

Other disorders of fluid, electrolyte and acid-base balance

385

2.21

10.97

1.1

580.96

517.81

ng/l

0.07

Sleep disorders (combined)

287

1207

1.56

10.92

1.1

1241.83

446.77

ng/l

0.57

283

Hard cardiovascular diseases

225

873

1.66

10.88

1.2

1.1

377.70

692.27

ng/l

0.54

203

Recurrent or chronic depression

121

440

1.99

10.87

1.1

3000.29

467.68

ng/l

0.48

124

Injuries to the head

315

1349

1.52

10.74

1.1

166.57

622.76

ng/l

1.97

296

Diseases of the ear and mastoid process

345

1160

1.51

10.64

1.1

312.89

628.87

ng/l

0.74

256

Mood disorders

297

1273

1.53

10.52

1.1

969.47

494.54

ng/l

0.27

301

Lumbar disc prolapse

168

762

1.76

10.45

1.1

84.40

479.47

ng/l

1.20

197

Non-Hodgkin lymphoma, all

5.47

10.41

1.3

1.1

1180.62

89.83

ng/l

—

Shoulder lesions

214

790

1.66

10.38

1.1

633.97

571.23

ng/l

0.06

201

Mood [affective] disorders

296

1274

1.53

10.36

1.1

989.85

493.01

ng/l

0.28

302

Other functional intestinal disorders

129

656

1.88

10.29

1.1

253.63

509.59

ng/l

0.62

155

Other shoulder lesions

102

3.45

10.27

1.1

75.78

370.00

ng/l

—

Migraine with aura and triptan purchases

203

2.67

10.24

1.1

66.22

400.80

ng/l

—

Depression

277

1236

1.55

10.22

1.1

1034.25

502.89

ng/l

0.29

294

Complications of surgical and medical care, not elsewhere classified

273

1268

1.55

10.18

1.1

130.74

640.16

ng/l

2.52

293

SLE (Finngen)

5.87

10.08

1.1

546.17

800.38

ng/l

—

Viral infections characterized by skin and mucous membrane lesions

123

654

1.88

10.02

1.2

1.1

282.59

436.42

ng/l

0.38

150

Vocal cord dysfunction

153

2.87

10.00

1.2

1.1

167.94

406.25

ng/l

0.76

Other extrapyramidal and movement disorders in other diseases

295

2.35

10.00

1.1

2543.93

429.49

ng/l

0.42

Heartburn

109

3.32

9.97

1.1

173.71

246.41

ng/l

—

Sequelae of cerebrovascular disease

368

2.13

9.96

1.1

71.06

355.06

ng/l

2.17

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

151

839

1.77

9.95

1.1

570.54

494.85

ng/l

0.06

198

Benign neoplasm of brain and other parts of central nervous system

3.92

9.85

1.2

1.1

75.63

39.99

ng/l

—

Symptoms and signs concerning food and fluid intake

3.62

9.78

1.1

252.71

154.91

ng/l

—

Other joint disorders

264

901

1.56

9.75

1.1

264.90

443.88

ng/l

0.58

218

Hypertension, essential

232

826

1.61

9.73

1.1

298.93

398.56

ng/l

0.22

201

Disorders of lipoprotein metabolism and other lipidaemias

227

892

1.60

9.65

1.1

260.92

673.20

ng/l

1.01

201

Enthesopathies of lower limb, excluding foot

266

2.38

9.41

1.1

104.09

545.37

ng/l

0.81

Injuries to the ankle and foot

198

1115

1.62

9.41

1.1

126.76

509.55

ng/l

2.16

255

Anxiety (asthma-related co-morbidities)

174

817

1.68

9.34

1.1

139.23

361.27

ng/l

0.85

194

Benign neoplasm of brain and other parts of central nervous system

3.76

9.33

1.2

1.1

75.63

540.60

ng/l

—

Persons encountering health services in other circumstances, wide

340

1205

1.47

9.30

1.1

166.86

548.57

ng/l

2.18

266

Arthropathies

273

907

1.53

9.23

1.1

233.56

443.88

ng/l

0.77

218

Abnormal findings on diagnostic imaging of lung

119

627

1.85

9.20

1.1

194.14

898.80

ng/l

1.61

158

Other viral diseases, not elsewhere classified

281

2.32

9.16

1.1

105.24

342.73

ng/l

1.07

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

411

2.07

9.15

1.1

197.64

276.21

ng/l

0.26

Complications of medical and surgical care

197

1165

1.61

9.15

1.1

599.60

560.32

ng/l

0.03

274

All anxiety disorders

176

853

1.66

9.11

1.1

139.23

370.31

ng/l

0.88

190

Herpesviral [herpes simplex] infections

142

2.90

9.10

1.1

475.36

369.78

ng/l

0.12

251

1021

1.54

9.10

1.1

682.98

483.47

ng/l

0.26

228

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

251

1021

1.54

9.10

1.1

682.98

483.47

ng/l

0.26

228

Other specified/unspecified arthritis

379

2.12

9.09

1.1

101.00

702.23

ng/l

1.40

Special screening examination for infectious and parasitic diseases

229

2.29

9.09

1.1

144.91

630.93

ng/l

0.79

Other anxiety disorders

130

641

1.80

9.08

1.1

207.19

403.61

ng/l

0.43

142

Hypothyroidism (congenital or acquired)

204

2.23

9.03

1.1

134.83

264.51

ng/l

0.45

Zoster [herpes zoster]

205

2.55

9.01

1.1

239.00

457.78

ng/l

0.58

Antihypertensive medication - note that there are other indications

188

620

1.66

8.98

1.1

180.35

261.46

ng/l

0.36

136

Fall on same level

333

1280

1.46

8.93

1.1

247.06

619.53

ng/l

1.20

289

Transient ischemic attack

127

582

1.81

8.93

1.1

155.91

794.90

ng/l

1.41

150

Pneumonia, organism unspecified

253

1203

1.52

8.90

1.1

761.29

544.11

ng/l

0.28

268

Any mental disorder

314

1066

1.48

8.87

1.1

589.15

453.86

ng/l

0.16

259

Other arthritis (FG)

430

2.03

8.84

1.1

132.19

686.37

ng/l

1.43

106

Other general symptoms and signs

4.85

8.70

1.1

—

171.00

—

Intestinal infectious diseases

260

1350

1.50

8.66

1.1

160.00

613.38

ng/l

2.02

298

Other and unspecified dermatitis

140

812

1.73

8.65

1.1

452.97

448.31

ng/l

0.01

189

Other diseases of urinary system

284

1074

1.49

8.60

1.1

813.48

370.18

ng/l

0.44

254

Polymyalgia rheumatica

147

2.80

8.57

1.1

35.20

401.78

ng/l

—

Other disorders of nervous system

3.63

8.56

1.3

1.1

358.20

626.09

ng/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

109

376

1.90

8.53

1.1

212.10

541.18

ng/l

0.58

Hypothyroidism, levothyroxine purchases

204

2.18

8.35

1.1

103.74

264.51

ng/l

0.61

Hypothyroidism and >3 levothyroxin purchases

204

2.18

8.35

1.1

103.74

264.51

ng/l

0.61

Diarrhoea and gastroenteritis of presumed infectious origin

191

1099

1.58

8.28

1.1

96.91

548.09

ng/l

2.80

240

Asthma, unspecified (mode), excluding more controls

135

610

1.74

8.26

1.1

307.65

681.23

ng/l

0.53

139

Brachial plexus disorders

118

2.98

8.18

1.1

202.00

530.71

ng/l

—

Hypertensive diseases

232

857

1.53

8.11

1.1

313.33

405.45

ng/l

0.19

210

Factors influencing health status and contact with health services

221

2.05

8.09

1.1

235.66

218.27

ng/l

0.04

Persons encountering health services for other counselling and medical advice, not elsewhere classified

305

1202

1.45

8.08

1.1

121.46

549.98

ng/l

2.86

265

Fitting and adjustment of other devices

438

1.94

8.07

1.1

92.69

565.47

ng/l

1.92

108

Other diseases of blood and blood-forming organs, wide

305

2.17

8.04

1.1

1357.16

394.48

ng/l

0.41

Acute upper respiratory infections of multiple and unspecified sites

203

979

1.56

7.97

1.1

1146.32

371.73

ng/l

0.57

231

Hypertension

231

856

1.53

7.96

1.1

313.33

405.45

ng/l

0.19

210

Selective serotonin reuptake inhibitors

275

981

1.48

7.94

1.1

472.16

459.58

ng/l

0.01

233

Hypothyroidism, strict autoimmune

188

785

1.59

7.88

1.1

494.28

544.20

ng/l

0.05

158

Acute upper respiratory infections

283

1219

1.46

7.86

1.1

739.32

495.62

ng/l

0.26

281

Falls/tendency to fall

319

1115

1.43

7.83

1.1

287.87

488.14

ng/l

0.60

255

Other disorders of glucose regulation and pancreatic internal secretion

100

3.12

7.82

1.1

53.71

248.04

ng/l

—

Asthma, unspecified (mode)

135

627

1.71

7.79

1.1

307.65

666.25

ng/l

0.52

143

Disorders of other endocrine glands

119

669

1.75

7.78

1.1

571.18

353.62

ng/l

0.31

157

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

108

600

1.80

7.75

1.0

1.1

188.00

390.91

ng/l

—

142

Dermatitis

163

1016

1.61

7.70

1.1

397.02

630.04

ng/l

0.41

235

Care involving use of rehabilitation procedures

172

1030

1.59

7.67

1.1

193.71

729.67

ng/l

1.84

234

Systemic lupus erythematosus

4.55

7.66

1.1

546.17

48.78

ng/l

—

Triptan medication for migraine, min. 3 purchases

156

755

1.63

7.59

1.1

138.27

380.00

ng/l

0.86

166

Asthma (only as main-diagnosis), excluding more controls

182

683

1.59

7.53

1.1

103.56

618.97

ng/l

1.23

155

Asthma (only as main-diagnosis)

184

702

1.58

7.52

1.1

103.56

607.06

ng/l

1.23

159

COPD/asthma/ILD related infections

294

1021

1.44

7.49

1.1

569.13

483.47

ng/l

0.11

228

COPD/asthma related infections

294

1021

1.44

7.49

1.1

569.13

483.47

ng/l

0.11

228

Lung diseases due to external agents

147

2.66

7.45

1.2

1.1

67.67

265.22

ng/l

1.32

Pain in thoracic spine

159

2.59

7.41

1.1

24.43

756.91

ng/l

—

Pure hypercholesterolaemia

190

820

1.56

7.38

1.1

229.76

714.67

ng/l

1.14

182

All pneumoniae

278

1337

1.44

7.36

1.1

704.08

511.59

ng/l

0.27

289

Pneumonias (Asthma/COPD co-morbidities)

276

1332

1.44

7.33

1.1

713.68

511.63

ng/l

0.28

289

Other diseases of upper respiratory tract

302

1105

1.43

7.31

1.1

619.22

570.84

ng/l

0.05

254

Inflammatory diseases of female pelvic organs

159

745

1.61

7.29

1.1

265.53

554.75

ng/l

0.44

156

Covid-19 confirmed case

399

1.96

7.28

1.1

133.08

584.93

ng/l

1.52

Conjunctivitis (acute, non atopic)

433

1.92

7.25

1.0

1.1

167.15

511.05

ng/l

0.84

103

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

269

1314

1.44

7.25

1.1

702.81

515.66

ng/l

0.26

285

Other symptoms and signs involving the digestive system and abdomen

191

2.42

7.23

1.1

262.50

707.49

ng/l

—

Gastrointestinal diseases

181

572

1.59

7.20

1.1

286.72

311.67

ng/l

0.06

139

All influenza

353

2.02

7.19

1.2

1.1

1130.86

408.27

ng/l

0.29

Explicit Sepsis

103

554

1.79

7.18

1.1

1125.12

540.09

ng/l

0.31

136

Triptan medication for migraine, single purchase ok

216

976

1.50

7.12

1.1

110.95

529.40

ng/l

1.47

225

Migraine, single triptan purchase ok & required. ICD-code if available is included

216

976

1.50

7.12

1.1

110.95

529.40

ng/l

1.47

225

Other disorders of ear

244

1114

1.46

7.04

1.1

538.00

582.80

ng/l

0.05

264

309

1159

1.41

7.03

1.1

679.15

494.04

ng/l

0.22

263

Rheumatism, unspecified

164

2.51

6.98

1.1

51.24

893.88

ng/l

—

Hypoglycaemia, other or unspecified

3.31

6.96

1.1

27.20

301.35

ng/l

—

Disorders of sclera, cornea, iris and ciliary body

142

880

1.62

6.93

1.1

270.78

485.60

ng/l

0.56

195

Disorders of vestibular function (Vertigo)

118

693

1.69

6.90

1.1

381.04

730.36

ng/l

0.43

165

Persons encountering health services in other circumstances

102

579

1.76

6.88

1.1

1594.12

556.18

ng/l

0.34

130

Injuries to the shoulder and upper arm

219

1247

1.47

6.88

1.1

687.30

535.01

ng/l

0.15

296

Iridocyclitis

333

2.02

6.82

1.1

60.06

385.22

ng/l

2.11

Diseases of the respiratory system

182

584

1.56

6.82

1.1

495.57

730.34

ng/l

0.27

125

Soft tissue disorders related to use, overuse and pressure

341

2.00

6.75

1.1

97.20

632.40

ng/l

1.39

Polyarthropathies

180

779

1.54

6.74

1.1

471.63

477.32

ng/l

0.01

200

Sleep apnoea

244

1146

1.45

6.72

1.1

630.63

459.25

ng/l

0.21

274

Complications of procedures, not elsewhere classified

207

1209

1.48

6.70

1.1

68.48

647.87

ng/l

3.08

285

Cough

111

624

1.71

6.69

1.1

1173.24

370.00

ng/l

0.60

158

Any reimbursement code in KELA

182

587

1.56

6.68

1.1

170.50

430.21

ng/l

0.85

114

Trochanteric bursitis

150

2.54

6.67

1.1

44.10

899.65

ng/l

—

Undetermined asthma, excluding more controls

144

2.58

6.66

1.2

1.1

649.25

141.43

ng/l

—

Undetermined asthma

144

2.58

6.66

1.2

1.1

649.25

145.00

ng/l

—

Septicaemia

529

1.77

6.56

1.1

1211.87

633.60

ng/l

0.27

114

SLE, strict definition

4.19

6.56

1.1

471.80

57.00

ng/l

—

SLE, ICD10

4.19

6.56

1.1

471.80

57.00

ng/l

—

Other diseases of arteries and capillaries

106

2.85

6.52

1.1

129.79

280.52

ng/l

—

Endocrine, nutritional and metabolic diseases

238

831

1.46

6.51

1.1

261.31

424.78

ng/l

0.45

173

Hypothyroidism, drug reimbursement

136

2.37

6.36

1.1

69.13

112.65

ng/l

—

Adrenocortical insufficiency

4.09

6.36

1.0

182.86

61.00

ng/l

—

Cystitis

216

902

1.47

6.29

1.1

277.85

366.04

ng/l

0.29

212

Sleep apnoea, including avohilmo

258

1186

1.41

6.26

1.1

657.44

563.45

ng/l

0.10

277

Benign neoplasm of meninges

115

2.71

6.17

1.2

1.1

1875.00

368.55

ng/l

—

ILD medications: azathioprine

206

2.24

6.15

1.2

1.1

465.73

283.05

ng/l

0.29

Diseases of inner ear

134

828

1.59

6.10

1.1

358.42

722.12

ng/l

0.52

197

Benign neoplasm of meninges

116

2.69

6.07

1.2

1.1

1875.00

307.30

ng/l

—

176

2.34

6.05

1.0

1.1

41.70

371.03

ng/l

—

Abnormalities of heart beat

509

1.76

6.03

1.2

1.1

397.41

360.02

ng/l

0.04

130

Other infectious diseases

2.94

5.99

1.2

1.1

55.17

552.45

ng/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.25

5.97

1.2

1.1

37.40

315.42

ng/l

—

Diseases of pulp and periapical tissues

575

1.71

5.97

1.1

566.86

367.65

ng/l

0.23

153

Temporomandibular joint disorders, including avohilmo

111

673

1.65

5.94

1.1

194.38

353.17

ng/l

0.45

145

117

714

1.63

5.94

1.1

85.75

381.28

ng/l

1.35

160

Internal derangement of knee

101

598

1.69

5.90

1.1

144.82

545.38

ng/l

1.42

156

Other septicaemia

487

1.76

5.84

1.1

1438.21

459.50

ng/l

0.42

105

Asthma and allergy, excluding more controls

146

2.44

5.84

1.1

45.60

674.53

ng/l

—

Disorders of choroid and retina

198

990

1.46

5.84

1.1

227.35

698.39

ng/l

1.59

237

All influenza (not pneumonia)

206

2.19

5.73

1.2

1.1

1948.00

122.45

ng/l

—

Mycoses

384

1.85

5.71

1.1

230.35

351.85

ng/l

0.39

Other enthesopathies

406

1.83

5.69

1.1

2736.46

495.56

ng/l

0.37

101

Menorrhagia

102

330

1.71

5.65

1.1

203.05

202.57

ng/l

0.00

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.73

5.65

1.4

1.0

3152.60

102.27

ng/l

—

Spinal stenosis

114

549

1.63

5.63

1.2

1.1

1309.19

573.21

ng/l

0.50

145

Problems related to lifestyle

145

2.42

5.61

1.1

83.43

240.45

ng/l

—

Acute sinusitis

133

797

1.56

5.60

1.1

85.44

441.72

ng/l

2.07

181

Functional dyspepsia

387

1.84

5.58

1.1

46.22

516.24

ng/l

1.32

Restless leg syndrome

152

2.38

5.54

1.1

4654.88

451.23

ng/l

—

Other external causes of accidental injury

232

820

1.42

5.53

1.1

245.08

558.04

ng/l

0.89

196

Impacted cerumen

122

2.55

5.53

1.2

1.1

70.00

393.47

ng/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

3.65

5.49

1.4

1.1

3152.60

53.08

ng/l

—

Exposure to other specified factors

192

1254

1.44

5.48

1.1

197.95

495.60

ng/l

1.48

285

Diaphragmatic hernia

522

1.71

5.47

1.1

352.83

800.11

ng/l

0.52

139

Asthma and allergy

151

2.36

5.46

1.1

45.60

640.66

ng/l

—

Dermatitis and eczema

284

1376

1.35

5.43

1.1

499.70

540.27

ng/l

0.05

300

Hypopituitarism

100

2.72

5.42

1.0

1.1

544.14

108.95

ng/l

—

Retention of urine

383

1.77

5.41

1.2

1.1

788.54

600.64

ng/l

0.10

105

Hypothyroidism, other/unspecified

226

1063

1.40

5.40

1.1

423.17

480.53

ng/l

0.08

236

Accidents

231

820

1.41

5.39

1.1

250.20

558.04

ng/l

0.86

196

Azathioprine

219

2.11

5.34

1.2

1.1

465.73

366.71

ng/l

0.13

Other heart diseases

135

575

1.55

5.32

1.1

961.07

332.50

ng/l

0.36

129

Bronchitis

274

1325

1.36

5.32

1.1

816.52

484.36

ng/l

0.33

309

Exposure to unspecified factor

250

1418

1.37

5.27

1.1

247.18

578.14

ng/l

1.00

318

Disorders of lens

169

722

1.48

5.26

1.2

1.1

348.73

723.20

ng/l

0.68

166

Acute tubulo-interstitial nephritis

151

897

1.49

5.25

1.2

1.1

190.92

692.07

ng/l

1.46

210

Pain associated with micturition

144

2.37

5.21

1.1

107.20

390.00

ng/l

—

Disorders of the thyroid gland

240

1137

1.38

5.20

1.1

446.71

462.94

ng/l

0.02

259

Other disorders of adrenal gland

3.36

5.17

1.0

1.1

182.86

49.49

ng/l

—

Ptosis of eyelid

133

2.42

5.12

1.2

1.1

936.00

325.58

ng/l

—

Chronic diseases of tonsils and adenoids

212

955

1.41

5.09

1.1

424.13

612.69

ng/l

0.28

216

Special screening examination for other diseases and disorders

2.85

5.07

1.2

1.1

149.43

227.75

ng/l

—

Diseases of external ear

505

1.69

5.02

1.1

97.57

483.98

ng/l

1.74

118

Unspecified urinary incontinence

2.70

5.00

1.2

1.1

114.67

449.04

ng/l

—

Hernia of abdominal wall, postoperative

179

2.18

4.98

1.0

1.1

150.13

321.03

ng/l

—

Otalgia

2.64

4.98

1.2

1.1

7.00

550.14

ng/l

—

Diabetic retinopathy, excluding more controls

183

1.91

4.95

1.1

321.63

406.82

ng/l

0.19

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

515

1.67

4.94

1.1

397.70

411.76

ng/l

0.02

113

Hypothyreosis and Thyroxine purchase for inclusion criteria

231

1110

1.37

4.91

1.1

416.00

473.15

ng/l

0.08

248

Other female pelvic inflammatory diseases

220

2.05

4.90

1.1

748.22

268.05

ng/l

—

Conductive and sensorineural hearing loss

192

941

1.41

4.86

1.1

570.70

643.76

ng/l

0.08

230

Renal tubulo-interstitial diseases

215

1193

1.38

4.86

1.1

157.79

626.90

ng/l

1.87

265

Pain and other conditions associated with female genital organs and menstrual cycle

291

1.88

4.85

1.1

84.12

100.47

ng/l

—

Voice disturbances

377

1.78

4.81

1.1

139.48

583.37

ng/l

1.02

Irritable bowel syndrome

399

1.76

4.81

1.1

37.78

477.39

ng/l

—

Anterior Iridocyclitis

299

1.88

4.76

1.1

47.13

345.61

ng/l

1.90

Constipation

217

1129

1.38

4.75

1.1

154.65

638.70

ng/l

1.83

266

Deviated nasal septum

515

1.65

4.68

1.2

1.1

1029.27

651.46

ng/l

0.21

127

Dentofacial anomalies [including malocclusion]

458

1.69

4.65

1.1

274.87

224.16

ng/l

0.12

114

Chronic sinusitis

105

672

1.56

4.63

1.2

1.1

223.50

498.32

ng/l

0.56

160

Rotator cuff syndrome

145

732

1.47

4.62

1.1

761.22

598.60

ng/l

0.12

187

Continuous positive airway pressure

271

1.85

4.61

1.2

1.1

1462.76

312.54

ng/l

0.56

Diseases of tongue

2.82

4.55

1.1

105.00

452.94

ng/l

—

Insulin, intermediate and long-acting

130

858

1.49

4.55

1.1

146.79

630.34

ng/l

2.26

200

Sensorineural hearing loss

178

882

1.41

4.54

1.1

636.48

665.35

ng/l

0.03

216

Asthma-related infections

140

942

1.46

4.52

1.1

268.76

577.64

ng/l

0.57

217

Asthma, hospital admission 2, infections

140

942

1.46

4.52

1.1

268.76

577.64

ng/l

0.57

217

Infections with a predominantly sexual mode of transmission

482

1.66

4.51

1.1

68.83

451.03

ng/l

1.13

104

Conjunctivitis

189

1188

1.39

4.48

1.1

166.77

501.15

ng/l

1.25

263

Osteopathies and chondropathies

131

840

1.48

4.47

1.1

160.00

624.70

ng/l

1.35

200

Polyuria

306

1.83

4.45

1.1

374.42

643.46

ng/l

0.34

Acute and subacute iridocyclitis

271

1.89

4.43

1.1

35.26

355.47

ng/l

1.79

Other and unspecified tonsillitis

461

1.62

4.42

1.1

795.56

295.28

ng/l

0.40

104

Hypothyroidism, strict autoimmune, 3 medication purchases required

203

1007

1.38

4.41

1.1

467.15

516.69

ng/l

0.06

222

Disorders of conjunctiva

205

1257

1.37

4.41

1.1

557.08

569.75

ng/l

0.01

276

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

106

2.46

4.37

1.1

3088.14

505.88

ng/l

—

Other disorders of eyelid

100

620

1.56

4.37

1.2

1.1

678.68

633.79

ng/l

0.03

149

Diseases of the skin and subcutaneous tissue

275

1044

1.32

4.36

1.1

964.41

512.49

ng/l

0.45

226

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

142

978

1.45

4.36

1.1

94.90

592.29

ng/l

2.03

235

Other strabismus

322

1.80

4.35

1.1

68.89

179.93

ng/l

—

Carpal tunnel syndrome

132

812

1.47

4.31

1.2

1.1

124.44

668.18

ng/l

1.60

190

External causes of morbidity and mortality

189

677

1.40

4.30

1.1

356.82

407.16

ng/l

0.09

161

Dementia

348

1.65

4.30

1.1

73.65

431.59

ng/l

1.37

Acetic acid derivatives and related substances

200

1.77

4.29

1.1

609.43

857.87

ng/l

0.17

Asthma (diagnoses ohter than nonallergic)

214

1358

1.35

4.26

1.1

210.00

603.88

ng/l

1.35

307

Sicca syndrome [Sjögren]

102

2.46

4.21

1.1

29.67

700.14

ng/l

—

Non-selective monoamine reuptake inhibitors

537

1.59

4.20

1.1

294.43

549.46

ng/l

0.47

137

Tongue abnormality

2.76

4.18

1.1

105.00

560.47

ng/l

—

Other bacterial intestinal infections

234

1.93

4.18

1.1

441.91

462.37

ng/l

0.02

Abnormal findings on diagnostic imaging of other body structures

153

2.16

4.17

1.2

1.1

1005.60

514.00

ng/l

—

Misadventures to patients during surgical and medical care

173

2.09

4.16

1.1

294.33

501.05

ng/l

—

Agranulocytosis

147

2.19

4.14

1.1

2730.67

389.47

ng/l

—

Genitourinary diseases

173

616

1.41

4.11

1.1

155.69

256.35

ng/l

0.57

144

Presence of other devices

278

1.84

4.11

1.2

1.1

646.99

438.06

ng/l

0.14

Childhood asthma (age<16), excluding more controls

120

2.19

4.10

1.1

90.29

77.60

ng/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

555

1.58

4.07

1.1

907.69

325.75

ng/l

0.51

131

Aplastic and other anaemias

574

1.55

4.06

1.2

1.1

272.10

443.62

ng/l

0.49

135

Insulin, fast-acting

551

1.58

4.06

1.1

284.09

452.25

ng/l

0.44

123

Benign paroxysmal vertigo

390

1.70

4.06

1.1

128.38

580.56

ng/l

1.14

Other and unspecified anaemias

533

1.58

4.05

1.2

1.1

276.03

437.20

ng/l

0.41

124

Any event in hilmo or specialist outpatient

+∞

4.04

1.0

0.0

—

Neoplasms

208

823

1.36

3.99

1.1

190.05

385.85

ng/l

0.68

177

Abnormal findings on examination of blood, without diagnosis

106

659

1.51

3.98

1.1

152.88

612.67

ng/l

2.12

161

Thyroiditis

2.54

3.96

1.1

20.00

332.89

ng/l

—

Other anaemias

535

1.57

3.95

1.2

1.1

276.03

434.09

ng/l

0.40

125

Childhood asthma (age<16)

122

2.15

3.95

1.1

90.29

75.76

ng/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

211

1.95

3.95

1.1

108.13

673.48

ng/l

—

Diabetic retinopathy

262

1.69

3.94

1.1

285.47

343.70

ng/l

0.17

Thyroiditis, ILD-related definition

144

2.16

3.91

1.1

73.00

615.18

ng/l

—

Retinal detachments and breaks

471

1.62

3.91

1.1

133.51

623.00

ng/l

1.60

113

Diseases of arteries, arterioles and capillaries (FINNGEN)

261

1.72

3.89

1.1

26.32

381.76

ng/l

2.55

Insulin, combination of fast acting with intermediate-acting or long-acting

142

925

1.42

3.88

1.1

218.97

618.18

ng/l

1.65

213

Dementia, including avohilmo

391

1.57

3.86

1.1

72.74

477.46

ng/l

1.79

111

Chronic periapical parodontitis

299

1.78

3.85

1.1

775.60

351.88

ng/l

0.30

Obesity related asthma

520

1.58

3.84

1.2

1.1

99.45

470.30

ng/l

1.23

121

Injury of muscle and tendon at shoulder and upper arm level

528

1.57

3.84

1.1

1358.06

537.67

ng/l

0.42

132

Other disorders of white blood cells

2.69

3.82

1.1

84.71

288.10

ng/l

—

Seronegative rheumatoid arthritis

139

2.17

3.82

1.1

214.91

490.85

ng/l

0.60

Other and unspecified drugs and medicaments

101

2.39

3.81

1.1

3088.14

471.63

ng/l

—

Allergic asthma (mode), excluding more controls

309

1.75

3.80

1.1

43.00

415.60

ng/l

0.71

Tinnitus

338

1.72

3.78

1.0

1.1

1607.25

651.14

ng/l

0.46

Localized swelling, mass and lump of skin and subcutaneous tissue

437

1.63

3.77

1.2

1.1

1962.00

451.00

ng/l

0.56

100

Immunodeficiencies

2.74

3.75

1.1

1081.00

239.66

ng/l

—

Dyspnoea

211

1221

1.32

3.72

1.1

590.84

516.15

ng/l

0.08

284

Allergic asthma (mode)

311

1.74

3.72

1.1

43.00

414.85

ng/l

0.71

Drug-induced neutropenia

2.46

3.71

1.2

1.1

3060.00

410.81

ng/l

—

Enterocolitis due to Clostridium difficile

122

2.22

3.66

1.0

1.1

760.20

437.29

ng/l

—

Disorders of psychological development

168

1.99

3.66

1.1

95.83

232.90

ng/l

—

Metatarsalgia

103

2.34

3.66

1.1

—

366.36

—

Insulin, fast-acting or short human

566

1.54

3.66

1.1

284.09

432.07

ng/l

0.39

130

Other cataract

491

1.52

3.64

1.1

757.74

743.94

ng/l

0.01

118

Injuries to the knee and lower leg

297

1341

1.27

3.62

1.1

827.56

469.25

ng/l

0.30

294

Ovarian cyst

354

1.54

3.61

1.1

1265.06

199.61

ng/l

0.40

Mouth breathing

101

681

1.48

3.59

1.1

566.44

674.21

ng/l

0.09

163

Early lumbar disc prolapse, operated

104

2.31

3.58

1.0

1.1

23.14

401.29

ng/l

—

Benign neoplasm of eye and adnexa

117

2.23

3.57

1.1

3934.00

280.40

ng/l

—

Tonsillectomy and adenotomy

146

730

1.39

3.54

1.1

606.04

371.19

ng/l

0.23

149

Behavioural syndromes associated with physiological disturbances and physical factors

507

1.56

3.54

1.1

41.67

443.64

ng/l

—

118

Unspecified fall

110

752

1.45

3.52

1.1

77.70

466.77

ng/l

1.94

186

Substance abuse, excluding more controls

128

794

1.41

3.46

1.1

708.17

514.42

ng/l

0.11

208

Asthma, including avohilmo

295

1362

1.26

3.42

1.1

230.02

592.76

ng/l

1.30

307

Diabetic neuropathy

119

2.18

3.39

1.2

1.1

809.20

298.94

ng/l

—

Urticaria and erythema

594

1.50

3.36

1.1

773.38

395.66

ng/l

0.22

130

Nontraumatic intracranial haemmorrhage

231

1.82

3.36

1.1

1480.49

394.83

ng/l

0.40

Fissure and fistula of anal and rectal regions

358

1.65

3.35

1.0

1.1

3218.28

850.31

ng/l

0.32

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

235

1242

1.29

3.34

1.2

1.1

696.86

530.46

ng/l

0.20

265

Melanocytic naevi

421

1.59

3.32

1.1

63.63

326.11

ng/l

—

Speech therapy

398

1.61

3.31

1.1

132.18

426.48

ng/l

1.52

Other problems related to primary support group, including family circumstances

164

1.97

3.30

1.2

1.1

323.00

266.86

ng/l

—

Other heart diseases, wide

242

1172

1.28

3.30

1.1

854.25

503.95

ng/l

0.32

260

Injuries to the thorax

670

1.46

3.30

1.1

135.69

630.96

ng/l

1.96

168

Other and unspecified disorders of skin and subcutaneous tissue

2.55

3.29

1.0

1.1

51.60

686.25

ng/l

—

Bacterial intestinal infections, IBD co-morbidities

233

1.81

3.28

1.1

429.50

467.56

ng/l

—

Glomerular diseases

263

1.75

3.25

1.1

187.27

390.54

ng/l

0.69

Benign neoplasm of eye and adnexa

122

2.14

3.25

1.1

3934.00

534.60

ng/l

—

Meniscus derangement

135

665

1.39

3.25

1.1

356.19

513.69

ng/l

0.33

169

Impingement syndrome of shoulder

346

1.65

3.25

1.2

1.1

121.64

897.02

ng/l

1.89

Other CVD (FINNGEN)

110

2.08

3.24

1.1

3161.60

440.13

ng/l

—

Benign neoplasm: Choroid

2.59

3.21

1.1

5893.50

145.82

ng/l

—

Tuberculosis, wide

2.44

3.21

1.1

222.67

96.42

ng/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

127

915

1.39

3.21

1.1

99.97

701.61

ng/l

2.27

229

Disorders of skin appendages

112

791

1.42

3.18

1.1

71.49

460.24

ng/l

1.79

173

Osteoporosis

288

1.69

3.17

1.1

236.36

348.98

ng/l

0.31

Achilles tendinitis

117

2.14

3.15

1.3

1.1

98.00

329.80

ng/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

104

2.22

3.15

1.1

4702.00

464.38

ng/l

—

Superficial injury of abdomen, lower back and pelvis

193

1.87

3.14

1.1

762.14

212.80

ng/l

—

Other diseases of pleura

562

1.47

3.14

1.1

439.25

560.09

ng/l

0.18

146

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

396

1.59

3.13

1.2

1.1

109.91

390.73

ng/l

0.69

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

503

0.56

3.12

1.1

136.17

765.05

ng/l

—

122

Glomerulonephritis

131

2.07

3.12

1.0

1.1

179.13

424.36

ng/l

—

Speech and linguistic disorders, excluding more controls

2.26

3.11

1.2

1.1

95.83

197.88

ng/l

—

L04AA Selective immunosuppressants

335

1.65

3.11

1.1

144.25

325.92

ng/l

0.87

Chronic gastritis

366

1.61

3.10

1.1

270.80

521.92

ng/l

0.50

Candidiasis

187

1.88

3.09

1.0

1.1

386.60

355.25

ng/l

—

Other acute lower respiratory infections

120

823

1.39

3.08

1.1

710.62

402.80

ng/l

0.25

192

Diseases of arteries, arterioles and capillaries

144

792

1.36

3.06

1.1

89.16

799.78

ng/l

2.40

198

Insulin medication

142

896

1.36

3.06

1.1

218.97

761.59

ng/l

1.55

203

Degenerative diseases of the nervous system

268

1.63

3.05

1.2

1.1

26.67

634.63

ng/l

—

Other complications of surgical and medical care, not elsewhere classified

119

2.11

3.03

1.1

57.60

465.64

ng/l

—

Benign neoplasms

195

846

1.31

3.03

1.1

384.62

372.09

ng/l

0.02

187

Dental caries

388

1.59

3.03

1.0

1.1

119.91

290.13

ng/l

1.07

103

Dentinal caries

344

1.62

3.01

1.0

1.1

131.90

252.61

ng/l

—

Disorders of synovium and tendon

115

742

1.40

3.00

1.2

1.1

81.17

592.45

ng/l

2.85

194

Use of hypnotics and sedatives

264

1219

1.25

2.99

1.1

602.02

454.04

ng/l

0.17

281

Benign neoplasm: Colon

105

565

1.43

2.99

1.1

641.36

677.78

ng/l

0.03

137

Cellulitis

308

1.66

2.99

1.1

844.50

311.27

ng/l

—

Opening and dilatation of root channel of tooth

2.36

2.98

1.2

1.1

87.43

290.78

ng/l

—

Other retinal disorders

134

790

1.36

2.98

1.1

239.85

816.30

ng/l

1.52

187

Bleeding

190

1066

1.30

2.96

1.1

772.48

588.71

ng/l

0.16

253

Personality disorders, excluding more controls

363

1.60

2.96

1.1

83.33

397.87

ng/l

—

Injury, poisoning and certain other consequences of external causes

146

538

1.36

2.95

1.1

449.13

521.84

ng/l

0.09

125

Chronic lower respiratory diseases

304

1335

1.23

2.94

1.1

500.82

548.28

ng/l

0.06

296

Benign neoplasms

244

1080

1.26

2.93

1.1

486.25

450.30

ng/l

0.06

250

Elevated blood glucose level

101

2.19

2.93

1.2

1.1

98.67

244.91

ng/l

—

Other diseases of stomach and duodenum

2.33

2.91

1.1

66.50

537.82

ng/l

—

Striking against or struck by other objects

532

1.49

2.91

1.1

2955.67

327.91

ng/l

0.41

119

Tuberculosis, IBD comorbidity

2.38

2.89

1.1

222.67

96.42

ng/l

—

Otitis externa, unspecified

149

1.95

2.89

1.1

170.17

387.61

ng/l

—

Other pleural conditions

115

2.09

2.88

1.0

1.1

108.80

451.00

ng/l

—

Other enthesopathy of foot (+metatarsalgia)

115

2.09

2.88

1.1

—

344.31

—

Varicella [chickenpox]

2.60

2.87

1.3

1.1

137.71

252.68

ng/l

—

Allergic contact dermatitis

178

1.86

2.85

1.3

1.1

801.25

308.46

ng/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

178

1.86

2.85

1.0

1.1

2626.50

455.89

ng/l

—

Diabetic retinopathy, strict definition

181

1.80

2.84

1.1

278.71

308.93

ng/l

—

Other disorders of patella

237

1.73

2.83

1.1

155.67

666.23

ng/l

—

Crohn disease

193

1.82

2.83

1.2

1.1

259.50

374.95

ng/l

0.16

Benign neoplasm: Colon

107

752

1.40

2.82

1.1

615.04

769.95

ng/l

0.17

198

Other disorders of skin and subcutaneous tissue

149

1031

1.33

2.81

1.1

699.24

598.76

ng/l

0.06

244

Senile cataract

139

639

1.35

2.80

1.2

1.1

373.15

783.31

ng/l

0.67

152

Abnormal weight loss

103

2.14

2.80

1.1

307.00

462.51

ng/l

—

Deforming dorsopathies

345

1.60

2.80

1.1

83.22

464.22

ng/l

—

Melanocytic naevi

440

1.53

2.80

1.1

63.62

524.35

ng/l

—

101

Benign neoplasm: Choroid

2.41

2.80

1.1

5893.50

170.67

ng/l

—

Intracerebral haemorrhage

130

2.00

2.79

1.2

1.1

1767.69

607.51

ng/l

—

Cardiac arrhythmias

154

768

1.33

2.79

1.1

1294.46

523.24

ng/l

0.43

175

Transport accidents

106

673

1.40

2.79

1.1

55.62

609.62

ng/l

2.28

164

Other and unspecified urticaria

299

1.64

2.79

1.1

71.75

334.00

ng/l

1.45

Noninfective enteritis and colitis

107

769

1.39

2.79

1.1

188.62

512.58

ng/l

0.98

175

Generalized anxiety disorder

194

1.81

2.79

1.0

1.1

26.43

424.80

ng/l

—

Diseases of the digestive system

668

1.42

2.78

1.2

1.1

800.91

426.07

ng/l

0.24

160

Crohn's disease of small intestine

2.17

2.77

1.2

1.1

25.86

350.57

ng/l

—

Nonsuppurative otitis media

318

1.58

2.76

1.1

132.49

271.17

ng/l

0.51

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

265

1.65

2.76

1.1

123.20

157.29

ng/l

—

Benign neoplasm of other and unspecified endocrine glands

166

1.87

2.75

1.1

161.86

194.17

ng/l

—

Sequelae of infectious and parasitic diseases

2.21

2.73

1.2

1.1

88.71

273.60

ng/l

—

Erysipelas

112

743

1.38

2.72

1.1

360.79

721.75

ng/l

0.61

160

Haemorrhoids and perianal venous thrombosis

395

1.55

2.72

1.1

690.09

516.30

ng/l

0.09

Endometriosis

341

1.47

2.70

1.1

662.73

200.18

ng/l

0.37

Maternal care for other conditions predominantly related to pregnancy

298

1.63

2.69

1.0

1.1

48.14

518.53

ng/l

—

Fracture of foot, except ankle

349

1.58

2.69

1.1

108.18

271.14

ng/l

0.91

Dental pulpitis 4

266

1118

1.24

2.68

1.1

472.25

443.22

ng/l

0.04

247

Dental pulpitis 1

266

1119

1.24

2.66

1.1

472.25

443.22

ng/l

0.04

247

Oxicams

181

1.64

2.66

1.2

1.1

60.20

899.80

ng/l

—

Propionic acid derivatives

226

1.54

2.66

1.0

1.1

382.72

788.76

ng/l

0.48

Bacterial, viral and other infectious agents

126

1.99

2.65

1.1

4257.78

207.20

ng/l

—

Colonic or urogenital fistula

414

1.52

2.65

1.1

2734.08

569.89

ng/l

0.36

Status post-ami

0.00

2.64

0.0

1.1

—

455.64

—

Fracture of rib(s), sternum and thoracic spine

399

1.53

2.62

1.1

66.40

555.67

ng/l

—

Vasomotor and allergic rhinitis

594

1.43

2.62

1.1

736.38

420.39

ng/l

0.18

129

Urticaria

488

1.48

2.61

1.1

76.06

446.10

ng/l

1.18

111

Gonarthrosis [arthrosis of knee](FG)

172

782

1.30

2.61

1.1

290.41

705.68

ng/l

1.01

195

Infections of the skin and subcutaneous tissue

132

989

1.33

2.61

1.1

359.75

536.47

ng/l

0.30

227

Weight loss

113

2.04

2.61

1.1

307.00

462.51

ng/l

—

Lateral epicondylitis

155

1.88

2.60

1.0

1.1

86.00

770.72

ng/l

—

Benign neoplasm of colon, rectum, anus and anal canal

119

626

1.36

2.60

1.1

527.74

663.87

ng/l

0.15

144

Malignant neoplasm of digestive organs

510

0.56

2.59

1.1

87.40

446.10

ng/l

—

138

Benign neoplasm of colon, rectum, anus and anal canal

130

881

1.33

2.58

1.1

493.62

714.92

ng/l

0.32

223

Other CVD

214

1.73

2.58

1.1

1989.62

417.41

ng/l

—

Injuries to the neck

345

1.57

2.58

1.1

206.27

317.94

ng/l

0.33

Superficial injury of lower leg

361

1.55

2.57

1.1

40.17

545.99

ng/l

1.16

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

185

1.79

2.56

1.1

3373.00

443.31

ng/l

—

Pruritus

128

1.96

2.54

1.0

1.1

3084.14

416.11

ng/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

362

1.55

2.54

1.1

173.60

368.86

ng/l

—

Other fall from one level to another

346

1.56

2.54

1.1

751.53

348.39

ng/l

0.34

Lymphoid leukaemia

2.43

2.54

1.0

1.1

995.80

89.62

ng/l

—

Superficial injury of hip and thigh

171

1.82

2.53

1.0

1.1

148.14

319.25

ng/l

—

Diseases of pulp and periapical tissues, including avohilmo

264

1117

1.23

2.52

1.1

472.25

443.22

ng/l

0.04

247

Injuries to the wrist and hand

237

1392

1.23

2.51

1.1

1089.87

442.62

ng/l

0.45

309

Burns and corrosions

201

1.75

2.51

1.0

1.1

146.00

217.66

ng/l

—

Bipolar affective disorders

277

1.63

2.51

1.1

50.17

244.52

ng/l

1.60

Hyperlipidaemia, other/unspecified

521

1.44

2.49

1.1

259.00

926.02

ng/l

1.16

128

Asthma, hospital admissions , main diagnosis only

191

1362

1.26

2.45

1.1

103.06

614.85

ng/l

2.73

304

Acute bronchitis

599

1.41

2.44

1.1

990.55

458.28

ng/l

0.30

131

Coagulation defects, purpura and other haemorrhagic conditions

264

1.63

2.43

1.1

2504.75

441.57

ng/l

0.71

Diseases of oral cavity, salivary glands and jaws

228

943

1.24

2.41

1.1

805.43

489.97

ng/l

0.24

228

Malignant neoplasm, wide definition for exclusion

215

1021

1.25

2.41

1.1

927.21

479.82

ng/l

0.43

221

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

215

1021

1.25

2.41

1.1

927.21

479.82

ng/l

0.43

221

Other diseases of anus and rectum

399

1.50

2.40

1.1

1152.17

756.79

ng/l

0.22

Inflammatory disease of uterus

189

1.75

2.40

1.1

83.70

201.47

ng/l

—

Other/unspecified synovitis and tenosynovitis

131

1.91

2.40

1.2

1.1

34.13

320.92

ng/l

—

Coronary revascularization (ANGIO or CABG)

553

0.66

2.39

1.1

1308.01

408.94

ng/l

0.35

147

Lymphoid leukaemia

2.35

2.38

1.0

1.1

995.80

286.24

ng/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

215

1023

1.24

2.37

1.1

927.21

479.82

ng/l

0.43

221

Intestinal malabsorption

2.43

2.37

1.1

—

306.77

—

Atopic dermatitis, strict definition with reimbursement

485

1.44

2.33

1.1

53.62

383.11

ng/l

0.91

100

Dislocation, sprain and strain of joints and ligaments at neck level

222

1.67

2.30

1.1

148.00

200.09

ng/l

—

Benign neoplasm: Transverse colon

119

1.94

2.30

1.1

1.2

68.33

629.56

ng/l

—

Atopic dermatitis, strict definition

476

1.44

2.29

1.1

53.62

435.39

ng/l

1.13

104

Presence of other functional implants

117

623

1.33

2.27

1.1

900.09

827.98

ng/l

0.05

147

Unspecific neurodegenerative disorder

310

1.47

2.26

1.1

36.02

555.93

ng/l

—

Other noninflammatory disorders of vagina

2.03

2.26

1.2

1.0

—

165.39

—

Other noninfective gastroenteritis and colitis

373

1.50

2.25

1.1

39.00

381.81

ng/l

2.72

Any dementia, excluding more controls

273

1.50

2.24

1.1

78.00

490.25

ng/l

—

Nutritional anaemias

671

1.36

2.24

1.1

886.11

424.38

ng/l

0.23

156

Fibroblastic disorders

286

1.58

2.24

1.2

1.1

138.64

683.56

ng/l

1.23

Use of pramipexole

294

1.57

2.23

1.1

5762.78

421.40

ng/l

—

Excessive, frequent and irregular menstruation

374

1.38

2.23

1.1

62.38

190.19

ng/l

1.48

Type 2 diabetes, wide definition

184

959

1.25

2.21

1.1

219.06

649.91

ng/l

1.23

221

Dental pulpitis 2

171

691

1.27

2.21

1.1

472.50

494.13

ng/l

0.03

166

Sequelae of injuries of neck and trunk

2.79

2.20

1.1

1.0

—

310.40

—

Emergency coronary revascularization (for ACS)

601

0.68

2.20

1.1

1226.15

506.55

ng/l

0.29

161

135

937

1.29

2.20

1.1

360.89

593.97

ng/l

0.29

221

Coronary artery bypass grafting

318

0.55

2.19

1.2

1.1

1555.28

461.09

ng/l

0.36

Fenamates

139

1.70

2.19

1.1

161.71

1035.00

ng/l

—

Hypokalaemia

143

1.82

2.18

1.2

1.1

81.00

273.93

ng/l

—

Benign neoplasm of other and unspecified endocrine glands

180

1.73

2.18

1.1

161.86

439.51

ng/l

—

Dislocation, sprain and strain of joints and ligaments of knee

143

1039

1.28

2.18

1.1

542.15

574.19

ng/l

0.04

227

Otitis externa

336

1.52

2.18

1.1

101.93

375.95

ng/l

1.43

Acute appendicitis, no complications

128

986

1.30

2.17

1.1

211.36

575.55

ng/l

1.13

223

Crohn's disease NAS

2.08

2.17

1.1

26.33

348.55

ng/l

—

Disorders of refraction and accommodation

400

1.47

2.16

1.1

114.10

149.31

ng/l

—

Other peripheral vertigo

108

1.95

2.15

1.0

1.1

154.60

479.60

ng/l

—

Other symptoms and signs involving the circulatory and respiratory systems

2.17

2.14

1.3

1.1

23.80

248.04

ng/l

—

Diseases of male genital organs

130

503

1.31

2.13

1.0

1.1

745.05

285.71

ng/l

0.77

128

909

1.29

2.13

1.1

375.01

614.02

ng/l

0.29

213

Other disorders of bone

290

1.55

2.12

1.1

40.20

350.28

ng/l

—

Heart failure and coronary heart disease

327

0.57

2.12

1.0

1.1

740.40

392.67

ng/l

—

Benign neoplasm: Transverse colon

123

1.88

2.11

1.1

68.33

532.33

ng/l

—

Atopic dermatitis

128

845

1.29

2.11

1.1

79.87

379.46

ng/l

1.62

174

Excessive attrition of teeth

378

1.37

2.10

1.0

1.1

420.21

892.49

ng/l

0.44

Pre-eclampsia

283

1.56

2.10

1.0

1.1

368.57

596.69

ng/l

—

Manic episode

3.21

2.09

1.0

1.2

—

632.40

—

Monoamine oxidase A inhibitors

160

1.75

2.09

1.1

—

382.05

—

Spondyloarthritis

244

1.60

2.09

1.1

573.33

397.85

ng/l

—

Other disorders of the genitourinary system

153

1.77

2.07

1.2

1.1

107.79

404.11

ng/l

—

Gonarthrosis

146

656

1.28

2.07

1.1

323.54

526.43

ng/l

0.48

169

Crohn disease (strict definition, require KELA, min 2 HDR)

2.08

2.06

1.2

1.1

32.80

426.31

ng/l

—

Pulmonary embolism

381

1.47

2.06

1.1

263.59

541.90

ng/l

0.65

Other obstetric conditions, not elsewhere classified

303

1.44

2.06

1.1

90.36

137.06

ng/l

0.25

Thrombocytopenia, unspecified

2.03

2.05

1.2

1.1

2697.86

295.34

ng/l

—

Hypermetropia

1.98

2.05

1.1

145.20

278.52

ng/l

—

Volume depletion

1.98

2.05

1.1

3649.83

288.34

ng/l

—

Alcohol use disorder, Swedish definition

121

868

1.29

2.05

1.1

390.44

638.00

ng/l

0.28

204

Keratitis

540

1.39

2.05

1.1

543.68

497.79

ng/l

0.05

125

Pulmonary heart disease

382

1.47

2.04

1.1

263.59

541.90

ng/l

0.65

Other diseases of lip and oral mucosa

230

1.61

2.04

1.1

2213.30

366.10

ng/l

—

Unspecified haematuria

505

1.38

2.03

1.0

1.1

1222.45

526.38

ng/l

0.40

136

Purpura and other haemorrhagic conditions

169

1.72

2.03

1.2

1.1

3987.10

382.67

ng/l

—

Hypotension

169

1.72

2.03

1.1

3161.60

431.15

ng/l

—

Type 1 diabetes

407

1.45

2.02

1.1

189.82

455.09

ng/l

0.76

Benign neoplasm: Sigmoid colon

223

1.62

2.02

1.2

1.1

649.75

480.96

ng/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.09

2.01

1.1

—

273.80

—

Other abnormal uterine and vaginal bleeding

236

1.51

2.01

1.2

1.1

494.13

139.13

ng/l

0.69

Chronic rhinitis, nasopharyngitis and pharyngitis

475

1.41

2.00

1.1

1137.64

385.39

ng/l

0.29

112

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

294

1.44

2.00

1.2

1.1

97.20

136.63

ng/l

—

Spondylopathies (FG)

185

1.68

2.00

1.2

1.1

685.60

485.08

ng/l

—

Dental pulpitis 2, only avohilmo

174

715

1.25

1.98

1.1

421.75

486.78

ng/l

0.10

171

Assault

201

1.65

1.98

1.1

707.40

129.97

ng/l

—

Dental caries 3

199

829

1.23

1.98

1.1

402.96

440.76

ng/l

0.06

195

Reimbursement for rheumatic diseases

127

992

1.28

1.97

1.1

430.21

627.36

ng/l

0.27

226

Iron deficiency anaemia

589

1.36

1.97

1.1

1061.20

456.31

ng/l

0.26

139

Other predominantly sexually transmitted diseases, not elsewhere classified

256

1.57

1.97

1.1

51.67

356.75

ng/l

—

Coxarthrosis [arthrosis of hip](FG)

110

608

1.31

1.97

1.1

722.74

784.89

ng/l

0.03

158

Fracture of lumbar spine and pelvis

256

1.56

1.96

1.1

1074.88

425.26

ng/l

—

Disorders of adult personality and behaviour

469

1.41

1.96

1.1

758.15

414.22

ng/l

0.27

108

Crohn disease (strict definition, require KELA)

2.03

1.95

1.2

1.1

32.80

426.31

ng/l

—

Type 1 diabetes, wide definition, subgroup 1

353

1.47

1.95

1.1

198.46

319.10

ng/l

0.51

Dental pulpitis 4, only avohilmo

264

1157

1.19

1.95

1.1

465.20

479.86

ng/l

0.02

258

Other nutritional deficiencies

143

1112

1.26

1.94

1.1

234.76

639.04

ng/l

1.18

258

Spondylolisthesis/Spondylolysis

202

1.64

1.94

1.1

68.50

663.13

ng/l

—

Arthrosis

164

722

1.25

1.94

1.1

271.83

489.61

ng/l

0.62

184

Superficial injury of head

321

1.50

1.94

1.0

1.1

157.25

432.90

ng/l

—

Sudden idiopathic hearing loss

127

1.82

1.93

1.2

1.1

2032.87

487.81

ng/l

—

Hernia

218

1226

1.21

1.92

1.0

1.1

324.62

531.25

ng/l

0.47

287

Female genital prolapse

282

1.41

1.92

1.1

269.35

215.03

ng/l

0.11

Secondary uncertain malignant neoplasm

157

1.72

1.92

1.1

3454.00

500.37

ng/l

—

Mental and behavioural disorders due to psychoactive substance use

132

984

1.27

1.91

1.1

708.17

547.09

ng/l

0.09

230

Statin medication

174

789

1.24

1.90

1.1

386.26

506.59

ng/l

0.20

188

Any dementia

300

1.43

1.90

1.1

78.00

607.15

ng/l

—

Dermatophytosis

165

1.70

1.90

1.1

161.10

341.18

ng/l

—

Angina pectoris

735

0.74

1.89

1.1

1475.75

664.83

ng/l

0.36

189

Phobic anxiety disorders

158

1.71

1.88

1.1

25.50

351.43

ng/l

—

Lesion of ulnar nerve

166

1.69

1.87

1.0

1.1

24.00

307.38

ng/l

—

Cluster headache, strict

2.66

1.86

1.0

—

196.25

—

Dental pulpitis 1, only avohilmo

264

1163

1.19

1.86

1.1

501.52

477.77

ng/l

0.03

260

Other (seronegative) rheumatoid arthritis, wide

260

1.54

1.86

1.1

200.50

385.77

ng/l

0.60

Paroxysmal tachycardia

301

1.46

1.85

1.1

2761.56

342.53

ng/l

—

Open wound of head

104

789

1.30

1.85

1.2

1.1

247.48

679.20

ng/l

1.01

186

Noninfectious colitis NAS

182

1.65

1.84

1.1

18.80

383.51

ng/l

—

Substance abuse

128

969

1.26

1.83

1.1

708.17

543.55

ng/l

0.09

227

Cerebral aneurysm, nonruptured

108

1.86

1.81

1.0

1.1

—

476.43

ng/l

—

Other disorders of bladder

145

1.73

1.81

1.1

3177.00

519.02

ng/l

—

Osteoporosis with pathological fracture (FG)

2.27

1.80

1.0

1.1

52.20

643.82

ng/l

—

Varicose veins of other sites

1.96

1.79

1.2

1.1

58.60

309.29

ng/l

—

Fracture at wrist and hand level

545

1.36

1.79

1.1

2415.27

391.44

ng/l

0.40

120

Injury of unspecified body region

1.96

1.79

1.0

1.1

229.80

254.29

ng/l

—

Type 1 diabetes, wide definition

360

1.44

1.79

1.1

198.46

307.84

ng/l

0.46

Hypertrophic scar

2.17

1.77

1.3

1.1

23.80

326.09

ng/l

—

Allergic urticaria

109

1.84

1.77

1.2

1.1

81.83

315.68

ng/l

—

Hypertrophic disorders of skin

2.10

1.76

1.3

1.0

23.80

371.00

ng/l

—

Other and unspecified iron deficiency

437

1.40

1.75

1.1

1741.11

568.29

ng/l

—

108

Burns and corrosions of external body surface, specified by site

154

1.69

1.75

1.0

1.1

168.17

250.25

ng/l

—

Streptococcal septicaemia

1.90

1.75

1.2

1.1

80.75

162.52

ng/l

—

Disorders of synovium and tendon in diseases classified elsewhere

3.35

1.75

1.0

1.1

—

633.17

ng/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

433

1.39

1.74

1.1

226.33

489.92

ng/l

0.40

Cluster headache, wide

2.51

1.74

1.0

—

196.25

—

Sequelae of external causes of morbidity and mortality

355

1.44

1.73

1.0

1.1

179.00

369.85

ng/l

—

COPD related to multimorbidity

459

0.66

1.72

1.2

1.1

132.03

551.09

ng/l

—

125

Budesonide

178

1.63

1.72

1.1

314.92

461.12

ng/l

0.18

Coxarthrosis

104

546

1.29

1.72

1.1

755.05

585.49

ng/l

0.09

146

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

456

1.38

1.72

1.2

1.1

109.91

444.74

ng/l

0.87

101

Torticollis

3.87

1.72

1.0

1.2

—

654.00

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.92

1.70

1.2

1.1

32.80

379.88

ng/l

—

Congenital malformations, deformations and chromosomal abnormalities

132

1016

1.25

1.69

1.1

179.88

382.04

ng/l

0.96

215

Dental caries 3, only avohilmo

199

846

1.20

1.68

1.1

397.00

434.44

ng/l

0.07

198

Arthropathies in other diseases classified elsewhere

2.39

1.68

1.0

1.2

—

538.68

—

Injuries to unspecified part of trunk, limb or body region

119

1.77

1.66

1.0

1.1

229.80

269.53

ng/l

—

Pulmonary heart disease, diseases of pulmonary circulation

417

1.39

1.65

1.1

263.59

499.29

ng/l

0.56

104

Other diseases of hard tissues of teeth

151

918

1.23

1.65

1.1

324.68

502.42

ng/l

0.33

222

Injury of other and unspecified intrathoracic organs

1.98

1.64

1.1

—

366.17

—

Polycystic ovarian syndrome, consortium definition

153

752

1.23

1.63

1.1

245.03

565.38

ng/l

0.57

154

Dental caries 1, only avohilmo

188

799

1.20

1.61

1.1

419.35

448.66

ng/l

0.05

191

Other medical care

560

1.33

1.61

1.1

174.35

779.48

ng/l

1.79

133

Dental caries 1

184

780

1.21

1.61

1.1

412.63

455.44

ng/l

0.07

188

Other and unspecified effects of external causes

437

1.37

1.60

1.2

1.1

66.36

441.99

ng/l

1.07

102

Protozoal diseases

2.51

1.60

1.1

—

81.83

—

Crohn disease (strict definition, all UC cases excluded)

2.07

1.59

1.2

1.1

44.80

412.23

ng/l

—

Other specified disorders of muscle

2.70

1.58

1.0

1.2

—

524.21

—

Myocardial infarction, strict

595

0.73

1.58

1.1

456.61

397.26

ng/l

0.09

152

Schizophrenia or delusion, excluding more controls

443

1.37

1.58

1.0

1.1

263.50

455.07

ng/l

0.35

116

Thyrotoxicosis

363

1.41

1.56

1.1

1081.50

569.58

ng/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

114

1.76

1.56

1.3

1.1

56.40

261.44

ng/l

—

Social phobias

1.85

1.55

1.1

20.60

357.88

ng/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

734

1.28

1.55

1.1

55.20

725.79

ng/l

3.15

174

Venous thromboembolism

104

799

1.26

1.55

1.1

884.72

660.40

ng/l

0.13

189

Dental caries, including avohilmo

183

779

1.20

1.55

1.1

412.63

455.44

ng/l

0.07

188

Speech and linguistic disorders

124

1.71

1.54

1.2

1.1

95.83

95.48

ng/l

—

Asthma, hospital admissions 3, pneumonia

508

1.34

1.54

1.1

421.50

421.77

ng/l

0.00

121

Asthma-related pneumonia or sepsis

508

1.34

1.54

1.1

421.50

421.77

ng/l

0.00

121

Sequelae of other and unspecified infectious and parasitic diseases

1.93

1.54

1.1

110.60

307.52

ng/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

118

933

1.24

1.54

1.1

226.56

510.86

ng/l

0.69

209

Open wound of wrist and hand

720

1.28

1.53

1.2

1.1

806.62

639.68

ng/l

0.13

164

Sub-endpoint used in defining T1D endpoints

450

1.36

1.53

1.1

189.82

324.67

ng/l

0.65

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

102

508

1.27

1.53

1.1

1109.43

306.63

ng/l

0.57

123

Obesity due to excess calories

772

1.27

1.53

1.1

273.60

487.36

ng/l

0.49

174

Other arrhythmias

143

897

1.22

1.52

1.1

1118.64

543.91

ng/l

0.48

211

Alcohol use disorder, ICD-based

667

1.29

1.52

1.1

55.20

779.67

ng/l

3.04

157

Superficial injury of thorax

193

1.56

1.50

1.1

168.67

353.57

ng/l

—

Mental and behavioural disorders due to alcohol

109

848

1.25

1.50

1.1

51.40

592.45

ng/l

3.32

202

Dental caries 1 and operation codes

204

883

1.19

1.50

1.1

787.90

448.18

ng/l

0.45

211

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

532

1.31

1.50

1.1

1312.47

736.98

ng/l

0.21

127

DVT of lower extremities and pulmonary embolism

571

1.31

1.48

1.1

242.43

417.63

ng/l

0.52

132

Benign neoplasm: Caecum

116

1.73

1.48

1.2

1.1

780.88

626.22

ng/l

—

Heart failure and bmi 25plus

379

0.69

1.46

1.1

378.90

889.76

ng/l

0.53

104

Plantar fascial fibromatosis

109

1.75

1.46

1.2

1.1

195.50

379.47

ng/l

—

Secondary parkinsonism

2.51

1.45

1.0

1.1

—

125.50

—

Secondary parkinsonism+Parkinsonism in other disease

2.51

1.45

1.0

—

136.20

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

169

1.45

1.44

1.1

1068.83

858.71

ng/l

—

Allergic rhinitis

519

1.32

1.43

1.0

1.1

28.57

394.32

ng/l

—

116

Cholecystectomy

145

1063

1.21

1.42

1.1

87.44

685.32

ng/l

2.65

251

Asthma-related pneumonia

507

1.32

1.42

1.1

450.69

421.77

ng/l

0.03

121

Type 2 diabetes

226

1153

1.16

1.39

1.1

362.03

652.19

ng/l

0.69

252

Adenomyosis (Endometriosis of uterus)

181

1.55

1.39

1.0

1.1

131.60

116.27

ng/l

—

Dental operations

150

637

1.21

1.39

1.1

492.44

256.10

ng/l

0.56

163

Transplanted organ and tissue status

142

1.62

1.38

1.2

1.1

1098.99

393.83

ng/l

—

GI-bleeding

415

1.35

1.38

1.1

220.54

398.08

ng/l

0.74

102

Benign neoplasm of breast

150

1.60

1.37

1.2

1.1

568.60

263.15

ng/l

—

COPD, hospital admissions

555

0.73

1.36

1.2

1.1

160.27

630.63

ng/l

1.85

154

Paracetamol of NSAID medication

138

1.46

1.36

1.0

1.1

282.00

559.24

ng/l

—

Diverticular disease of intestine

145

800

1.20

1.35

1.1

355.66

604.16

ng/l

0.38

189

Ischemic heart diseases

124

944

0.82

1.35

1.1

560.48

577.35

ng/l

0.02

224

Heart failure, strict

652

0.77

1.35

1.0

1.1

282.87

783.76

ng/l

0.89

170

Hereditary corneal dystrophies

0.00

1.34

0.0

1.1

—

97.75

—

Dental caries 2, only avohilmo

172

1148

1.18

1.34

1.1

213.61

474.51

ng/l

0.82

251

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.15

1.33

1.0

—

179.63

—

Coronary atherosclerosis

102

813

0.81

1.32

1.1

489.58

631.88

ng/l

0.16

202

Ischaemic heart disease, wide definition

122

927

0.82

1.32

1.1

539.73

584.83

ng/l

0.05

221

Primary open-angle glaucoma, strict

333

1.38

1.30

1.2

1.1

2259.94

600.12

ng/l

0.37

Malignant neoplasm

203

1033

1.17

1.30

1.1

1023.25

467.37

ng/l

0.65

229

Pre-eclampsia or eclampsia

317

1.39

1.30

1.0

1.1

368.57

560.08

ng/l

—

Fracture of lower leg, including ankle

115

940

1.22

1.29

1.1

250.65

588.16

ng/l

1.05

212

Sleep disorders, other/unspecified

2.36

1.29

1.0

1.1

—

33.20

—

Allergic conjunctivitis

122

992

1.21

1.28

1.1

220.50

492.61

ng/l

0.69

219

Benign neoplasm: Sigmoid colon

251

1.44

1.28

1.2

1.1

649.75

363.77

ng/l

—

Perforation of tympanic membrane

138

1.60

1.26

1.1

95.67

454.36

ng/l

—

Missing teeth due to accident, extraction or parodontitis

162

1.55

1.25

1.1

141.70

373.78

ng/l

—

Other benign neoplasms of skin

545

1.29

1.25

1.1

554.53

554.51

ng/l

0.00

131

Personality disorders

440

1.32

1.25

1.1

83.33

449.11

ng/l

—

Other diseases of the digestive system

423

1.32

1.24

1.1

238.92

394.69

ng/l

0.61

103

Fall involving bed

2.41

1.24

1.0

1.1

—

29.67

—

Diseases of middle ear and mastoid

123

835

1.21

1.24

1.1

106.22

496.03

ng/l

1.75

175

Other symptoms and signs involving the urinary system

123

1.63

1.23

1.1

—

423.22

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

163

1.54

1.22

1.0

1.1

128.20

321.12

ng/l

—

Ulcer of lower limb, not elsewhere classified

163

1.54

1.22

1.1

92.14

487.95

ng/l

—

Papulosquamous disorders

627

1.26

1.22

1.1

446.05

568.16

ng/l

0.11

143

Ulcer of vagina/vulva

2.64

1.21

1.0

1.1

—

66.50

—

COPD, early/later onset

561

0.75

1.21

1.2

1.1

153.48

626.95

ng/l

1.92

155

Dental caries 3 and operation codes

209

927

1.16

1.21

1.1

790.88

435.28

ng/l

0.48

218

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

116

1.64

1.21

1.1

655.63

632.82

ng/l

—

Disorder of lipoprotein metabolism, unspecified

180

1.50

1.20

1.1

146.38

812.20

ng/l

—

Thyrotoxicosis with diffuse goitre

180

1.50

1.20

1.0

1.1

1982.00

1029.42

ng/l

—

All-cause Heart Failure

641

0.79

1.20

1.0

1.1

282.87

787.73

ng/l

0.89

169

Cardiodefibrillation

500

0.72

1.19

1.0

1.1

147.00

642.87

ng/l

—

142

Gastroduodenal ulcer

322

1.36

1.19

1.1

79.08

551.60

ng/l

1.61

Thoracic aortic aneurysm

181

1.49

1.18

1.1

19.98

826.27

ng/l

—

Other benign neoplasms of skin

540

1.27

1.17

1.1

554.53

635.25

ng/l

0.06

123

Irregular menses

641

1.23

1.17

1.1

185.42

373.61

ng/l

0.43

129

Polyp of the female genital tract

302

1.29

1.17

1.1

53.76

212.58

ng/l

1.50

Adenocarcinoma and ductal carcinoma of pancreas

0.00

1.16

0.0

1.1

—

119.12

—

Congenital malformations of the circulatory system

224

1.43

1.16

1.1

103.00

324.50

ng/l

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

182

1.49

1.15

1.1

70.14

548.33

ng/l

—

Mixed and other personality disorders

110

1.64

1.15

1.0

1.1

23.60

329.54

ng/l

—

Acne vulgaris

110

1.64

1.15

1.1

31.74

326.95

ng/l

—

Benign neoplasm: Ascending colon

158

1.52

1.14

1.1

1029.00

500.95

ng/l

—

Ganglion

266

1.39

1.14

1.1

51.80

665.49

ng/l

—

Anti-inflammatory and antirheumatic products, non-steroids

226

1.31

1.13

1.1

472.79

788.76

ng/l

0.32

Other disorders of teeth and supporting structures

309

1.36

1.13

1.1

157.46

301.97

ng/l

0.69

FESS (DNB20)

183

1.48

1.13

1.3

1.1

552.43

389.02

ng/l

—

Persistent mood disorders

275

1.38

1.13

1.1

19.43

594.17

ng/l

—

Dental caries 2 and operation codes, only avohilmo

160

849

1.17

1.12

1.1

89.76

904.39

ng/l

2.29

167

Contusion of ankle

2.01

1.12

1.0

1.1

—

29.67

—

Benign neoplasm: Rectum, anus and anal canal

250

1.40

1.12

1.1

569.44

448.24

ng/l

—

Ménière disease

111

1.62

1.12

1.2

1.1

1610.38

436.67

ng/l

—

Diabetes, varying definitions

235

1235

1.14

1.11

1.1

342.27

623.14

ng/l

0.70

266

Explicit bacterial Sepsis

119

1.60

1.11

1.2

1.1

89.78

431.85

ng/l

—

Benign neoplasm: Caecum

127

1.58

1.11

1.2

1.1

780.88

367.67

ng/l

—

severe traumatic brain injury, does not include concussion

276

1.38

1.10

1.1

77.00

346.98

ng/l

—

Endometriosis of ovary

250

1.40

1.10

1.1

1129.17

98.02

ng/l

—

Diabetes mellitus

236

1240

1.14

1.10

1.1

342.27

620.96

ng/l

0.70

267

Dental caries 2

172

1167

1.16

1.10

1.1

213.61

467.87

ng/l

0.80

255

Dental caries 2 and operation codes

169

1158

1.16

1.10

1.1

87.71

489.17

ng/l

2.68

253

Obesity and other hyperalimentation

128

1071

1.18

1.10

1.1

352.00

509.55

ng/l

0.34

247

Diabetes medication

233

1247

1.14

1.09

1.1

336.62

616.31

ng/l

0.71

272

Amyloidosis

2.39

1.09

1.0

1.1

—

50.50

—

COPD, hospital admission 2, with asthma infections

361

0.71

1.09

1.2

1.1

65.60

554.99

ng/l

—

Pacemaker

399

0.71

1.08

1.0

1.1

503.17

467.28

ng/l

—

107

Rheumatoid arthritis

442

1.28

1.07

1.1

157.00

631.92

ng/l

1.16

108

Schizophrenia

267

0.64

1.07

1.1

173.60

244.93

ng/l

—

Medical treatment for female infertility

303

1.35

1.07

1.0

1.1

83.00

547.60

ng/l

—

Benign neoplasm: Rectum

219

1.42

1.06

1.2

1.1

631.63

504.76

ng/l

—

Methotrexate

194

1.45

1.06

1.3

1.1

242.44

502.60

ng/l

—

Substance use, excluding alcohol

313

1.34

1.06

1.0

1.1

1841.67

329.48

ng/l

—

Appendectomy

138

1135

1.17

1.06

1.1

127.24

509.25

ng/l

2.10

259

Diseases of salivary glands

279

1.36

1.05

1.1

44.40

326.71

ng/l

—

Urolithiasis

471

1.27

1.05

1.1

88.78

502.64

ng/l

—

115

COPD

553

0.77

1.05

1.2

1.1

153.48

481.01

ng/l

1.39

147

Other metabolic disorders

178

1.46

1.05

1.0

1.1

130.17

306.36

ng/l

—

Familial hypercholesterolemia

203

1.43

1.05

1.1

65.47

707.56

ng/l

—

Unspecified acute lower respiratory infection

203

1.43

1.05

1.1

108.36

134.52

ng/l

—

Adhesive capsulitis of shoulder

203

1.43

1.04

1.1

1846.44

787.73

ng/l

—

Heart failure,strict

613

0.80

1.04

1.0

1.1

306.56

754.58

ng/l

0.67

152

Disorders of tooth development and eruption

1.71

1.04

1.1

42.60

171.14

ng/l

—

Benign neoplasm: Ascending colon

162

1.48

1.04

1.1

1029.00

396.97

ng/l

—

Benign neoplasm of breast

162

1.48

1.04

1.2

1.1

568.60

382.03

ng/l

—

Fall on and from stairs and steps

384

1.30

1.03

1.1

107.60

367.60

ng/l

—

Alcohol abuse, main dg, excluding more controls

212

1.42

1.03

1.1

90.17

284.11

ng/l

—

Panic disorder

187

1.45

1.03

1.1

34.50

474.31

ng/l

—

Other peripheral vascular diseases

1.64

1.03

1.1

34.20

530.71

ng/l

—

Diseases of appendix

162

1279

1.15

1.03

1.1

213.23

511.53

ng/l

1.12

292

Poisoning by drugs, medicaments and biological substances

367

1.31

1.02

1.1

167.00

515.53

ng/l

—

Other hearing loss

327

1.32

1.01

1.2

1.1

1383.75

537.18

ng/l

0.49

Retinal breaks without detachment

230

1.39

1.01

1.2

1.1

77.20

409.18

ng/l

—

Psoriatic and enteropathic arthropathies

147

1.50

1.00

1.0

1.1

1351.50

451.87

ng/l

—

Pleural effusion

180

1.45

1.00

1.0

1.1

131.30

675.26

ng/l

—

Adalimumab

131

1.53

0.99

1.1

355.00

273.50

ng/l

—

Blepharochalasis

413

1.28

0.99

1.1

1156.50

837.95

ng/l

0.16

104

Other chronic obstructive pulmonary disease

534

0.78

0.99

1.2

1.1

153.48

493.81

ng/l

1.43

143

Corneal ulcer

265

1.36

0.99

1.2

1.1

328.67

359.93

ng/l

—

Squamous cell neoplasms and carcinomas of the skin

123

1.55

0.99

1.1

655.63

408.91

ng/l

—

Early lumbar disc prolapse operation

164

1.47

0.99

1.0

1.1

23.14

260.76

ng/l

—

Car occupant injured in other and unspecified transport accidents

274

1.35

0.98

1.1

59.00

356.27

ng/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

274

1.35

0.98

1.1

228.43

557.14

ng/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

117

809

1.18

0.98

1.1

653.36

437.65

ng/l

0.14

174

Dialysis, with operation codes

181

1.44

0.98

1.1

190.75

345.45

ng/l

—

Chronic kidney disease

377

1.29

0.98

1.1

326.63

507.36

ng/l

0.34

Graves ophthalmopathy

0.00

0.98

0.0

1.1

—

40.43

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.98

0.0

1.1

—

125.50

—

Appendicitis, broad definition

160

1273

1.15

0.97

1.1

213.23

514.77

ng/l

1.13

290

Retinal detachment with retinal break

173

1.45

0.97

1.1

116.57

477.53

ng/l

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

215

1.40

0.97

1.1

70.14

494.85

ng/l

—

Other diseases of pancreas

1.63

0.97

1.2

1.1

140.20

556.69

ng/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

301

1.33

0.96

1.1

86.00

349.46

ng/l

—

Ethmoidectomy

190

1.42

0.96

1.3

1.1

552.43

365.13

ng/l

—

Poisoning by medicine

336

1.31

0.96

1.1

181.57

558.73

ng/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

301

0.71

0.95

1.2

1.1

65.60

609.91

ng/l

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.95

0.0

1.1

—

63.29

—

Acute appendicitis

150

1230

1.15

0.94

1.1

213.23

528.86

ng/l

1.19

282

Male infertility

1.78

0.94

1.0

1.1

—

359.28

—

Contact with sharp glass

1.90

0.94

1.0

1.1

—

395.36

—

Acne

133

1.50

0.94

1.1

31.74

281.72

ng/l

—

Specific personality disorders

373

1.29

0.93

1.1

115.00

505.68

ng/l

—

Care involving dialysis

101

1.59

0.93

1.1

130.00

411.25

ng/l

—

Artrosis, including avohilmo

196

949

1.13

0.92

1.1

190.81

463.27

ng/l

1.26

238

Obesity

125

1064

1.16

0.92

1.1

352.00

511.57

ng/l

0.35

246

Endometriosis ASRM stages 3,4

330

1.30

0.92

1.1

970.43

454.12

ng/l

—

Effects of other external causes

2.15

0.91

1.0

—

548.40

—

Gastric ulcer

218

1.38

0.91

1.1

69.66

656.90

ng/l

—

Retinal vascular occlusion

143

1.47

0.89

1.1

205.67

538.00

ng/l

—

Calculus of kidney and ureter

429

1.26

0.89

1.1

86.75

540.04

ng/l

—

104

Acute suppurative otitis media

417

1.25

0.89

1.1

171.54

300.83

ng/l

0.51

Phlebitis and thrombophlebitis (not including DVT)

315

1.30

0.88

1.1

2016.50

241.52

ng/l

0.50

Impetigo

1.79

0.87

1.1

—

542.88

—

Endometriosis of pelvic peritoneum

234

1.35

0.87

1.1

66.60

103.57

ng/l

—

Retinal vascular disorders

144

1.46

0.87

1.1

205.67

523.05

ng/l

—

Gingivitis and periodontal diseases

203

931

1.13

0.87

1.1

725.38

489.97

ng/l

0.23

228

Disorders of gallbladder, biliary tract and pancreas

209

1201

1.12

0.87

1.1

243.04

619.43

ng/l

0.98

279

Thyrotoxicosis, other and/or unspecified

264

1.33

0.85

1.1

207.63

773.74

ng/l

—

Benign neoplasm: Rectum, anus and anal canal

264

1.33

0.85

1.1

569.44

348.63

ng/l

—

Inflammatory bowel disease

514

1.23

0.84

1.2

1.1

227.30

496.17

ng/l

0.56

116

Any event in cancer register

204

1080

1.12

0.83

1.1

973.61

479.55

ng/l

0.46

238

Follicular cysts of skin and subcutaneous tissue

274

1.32

0.83

1.0

1.1

143.60

432.43

ng/l

—

Postmenopausal bleeding

231

1.26

0.83

1.0

1.1

101.23

259.59

ng/l

0.94

Adverse effects, not elsewhere classified

292

1.30

0.82

1.2

1.1

71.00

367.98

ng/l

—

Single spontaneous delivery

346

0.80

0.82

1.1

216.92

199.01

ng/l

0.04

Degenerative macular diseases

138

1.45

0.81

1.1

209.43

409.12

ng/l

—

Peritonsillar abscess

302

1.29

0.80

1.1

490.20

538.93

ng/l

—

Flat foot [pes planus] (acquired)

122

1.48

0.80

1.0

1.1

34.40

447.61

ng/l

—

Salpingitis and oophoritis

250

1.32

0.79

1.2

1.1

111.78

712.65

ng/l

—

Atrial fibrillation and flutter

342

1.22

0.79

1.0

1.1

1817.67

345.90

ng/l

0.39

IBD patients in KELA-register

365

1.26

0.79

1.2

1.1

108.44

286.69

ng/l

0.88

Cardiomyopathy, Hypertrophic obstructive

0.00

0.79

0.0

1.0

—

42.40

—

Benign neoplasm: Lip

0.00

0.79

0.0

1.1

—

71.17

—

Benign neoplasm: Lip

0.00

0.79

0.0

1.1

—

37.40

—

Adenocarcinoma of pancreas

0.00

0.79

0.0

1.1

—

40.60

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

259

1.31

0.79

1.1

228.89

270.35

ng/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.78

0.0

1.0

—

70.60

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

1.1

—

50.17

—

Lichen planus

173

1.39

0.78

1.1

91.14

433.19

ng/l

—

Rheumatoid arthritis, including avohilmo

583

1.20

0.78

1.2

1.1

144.50

443.92

ng/l

1.02

133

Cardiomyopathy

246

0.69

0.77

1.0

1.1

669.67

328.81

ng/l

—

Graves ophthalmopathy, strict

0.00

0.77

0.0

1.1

—

40.43

—

Cholecystitis

165

1.40

0.77

1.2

1.1

205.67

544.31

ng/l

0.86

Disorders of vitreous body

761

1.17

0.76

1.2

1.1

1116.05

701.09

ng/l

0.22

186

Other respiratory disorders and diseases

261

1.30

0.76

1.1

453.43

345.84

ng/l

—

Other diseases of the respiratory system

261

1.30

0.76

1.1

453.43

345.84

ng/l

—

Bicipital tendinitis

1.70

0.75

1.1

1.2

—

356.52

—

Pedal cyclist injured in transport accident

341

1.26

0.75

1.1

21.89

306.10

ng/l

—

Pyothorax

1.70

0.75

1.1

—

391.92

—

Exclusions for E4_PCOS_CONSORTIUM

157

874

1.13

0.73

1.1

518.33

499.89

ng/l

0.02

194

Other disorders of amniotic fluid and membranes

183

1.35

0.72

1.2

1.1

34.60

216.34

ng/l

—

Psychotic depression

1.67

0.72

1.1

—

446.56

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

101

596

1.16

0.72

1.1

542.58

674.63

ng/l

0.12

140

Hallux rigidus

185

1.35

0.71

1.1

5251.71

428.45

ng/l

—

Other noninflammatory disorders of uterus, except cervix

215

1.27

0.71

1.1

62.09

161.26

ng/l

1.12

Scabies

1.58

0.71

1.2

1.0

—

414.99

—

Early onset COPD, excluding more controls

255

1.29

0.71

1.2

1.1

119.58

308.63

ng/l

—

Retinoschisis and retinal cysts

1.93

0.70

1.0

—

51.80

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.93

0.70

1.0

1.1

—

62.50

—

Multiple myeloma

1.93

0.70

1.0

1.1

—

62.50

—

Volvulus

1.93

0.70

1.2

1.1

—

57.60

—

Bronchitis, not specified as acute or chronic

109

1.47

0.70

1.1

1275.60

287.50

ng/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

210

1161

1.10

0.70

1.1

337.96

643.18

ng/l

0.72

256

Coeliac disease

177

1.36

0.70

1.3

1.1

2190.29

378.19

ng/l

—

Fracture of skull and facial bones

309

1.26

0.70

1.1

112.78

420.63

ng/l

—

Cholelithiasis

169

1062

1.12

0.70

1.1

59.02

676.22

ng/l

2.76

246

Insulin, fast-acting (human)

212

1.32

0.70

1.1

101.14

263.05

ng/l

—

Paralytic ileus and intestinal obstruction

336

1.25

0.69

1.1

263.63

591.98

ng/l

—

Persons with potential health hazards related to communicable diseases

641

1.18

0.69

1.1

100.00

412.38

ng/l

1.03

129

Disorders of vitreous body and globe

775

1.16

0.69

1.2

1.1

1116.05

690.48

ng/l

0.23

189

Colon adenocarcinoma

144

0.62

0.69

1.1

—

560.95

—

Atrial fibrillation and flutter with reimbursement

266

1.23

0.69

1.0

1.1

458.50

373.74

ng/l

—

Psoriasis

445

1.21

0.69

1.0

1.1

690.92

553.42

ng/l

0.07

100

Trigger finger

169

1.36

0.69

1.1

56.43

792.69

ng/l

—

Other articular cartilage disorders

1.86

0.68

1.0

1.2

—

40.50

—

Other surgical follow-up care

1.86

0.68

1.0

1.1

—

421.38

—

Primary angle-closure glaucoma

1.67

0.68

1.4

1.1

—

83.70

—

Schizophrenia, schizotypal and delusional disorders

530

1.19

0.66

1.0

1.1

276.31

457.59

ng/l

0.34

121

Polyarthrosis

256

1.27

0.66

1.1

15.56

641.46

ng/l

—

Haemorrhagic and haematological disorders of fetus and newborn

1.60

0.65

1.1

1.0

—

78.50

—

Multiple myeloma and malignant plasma cell neoplasms

1.59

0.65

1.3

1.1

—

63.38

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

1.59

0.65

1.3

1.1

—

63.38

—

Coxarthrosis, primary

104

791

1.14

0.65

1.1

754.64

723.78

ng/l

0.01

203

Malignant neoplasm of colon

178

0.67

0.64

1.1

—

485.32

—

Palmar fascial fibromatosis [Dupuytren]

189

1.32

0.64

1.2

1.1

70.40

470.44

ng/l

—

Alcohol abuse, main dg

233

1.29

0.64

1.1

90.17

215.22

ng/l

—

Gestational diabetes (for exclusion)

401

1.18

0.64

1.1

130.17

413.36

ng/l

0.47

Benign neoplasm: Rectum

242

1.28

0.64

1.2

1.1

631.63

321.92

ng/l

—

Preterm labour and delivery

413

1.21

0.64

1.2

1.1

4681.88

471.64

ng/l

—

Macular cyst

1.73

0.64

1.0

1.1

—

93.88

—

Other disorders of the musculoskeletal system and connective tissue

198

1.31

0.63

1.1

22.64

406.39

ng/l

—

Inflammatory bowel disease, strict (require KELA)

377

1.22

0.63

1.2

1.1

108.44

279.95

ng/l

0.85

Supervision of normal pregnancy

207

0.77

0.63

1.1

4179.60

95.55

ng/l

—

Other and unspecified nonorganic psychotic disorders

305

1.25

0.63

1.0

1.1

498.17

315.73

ng/l

—

Diseases of liver

506

1.19

0.62

1.1

69.00

714.81

ng/l

2.04

113

Iron deficiency anaemia secondary to blood loss (chronic)

199

1.31

0.62

1.3

1.1

41.33

497.55

ng/l

—

Other diseases of gallbladder

1.64

0.62

1.0

1.1

—

706.60

—

Medical abortion

126

608

1.13

0.61

1.1

992.93

485.73

ng/l

0.28

128

Correction of physiology of bite - very demanding therapy visit

1.67

0.61

1.0

1.1

—

72.60

—

Smoking dependency

113

1.42

0.61

1.1

3227.20

243.23

ng/l

—

Biological medication for rheuma

244

1.27

0.61

1.1

310.63

376.07

ng/l

—

Haemorrhage from respiratory passages

462

1.19

0.61

1.1

987.68

270.04

ng/l

0.43

125

Gout

304

1.23

0.60

1.0

1.2

621.25

593.56

ng/l

0.02

Antenatal screening

215

0.79

0.60

1.1

588.14

87.34

ng/l

—

Injury of muscle and tendon at wrist and hand level

200

1.30

0.60

1.1

114.63

358.15

ng/l

—

Other chronic obstructive pulmonary disease, including avohilmo

677

0.86

0.60

1.2

1.1

132.95

560.10

ng/l

2.15

182

Non-rheumatic valve diseases

594

1.14

0.59

1.2

1.1

862.69

736.78

ng/l

0.07

142

Cholelithiasis, broad definition with cholecystitis

175

1090

1.10

0.59

1.1

91.30

663.19

ng/l

2.49

251

Foreign body in alimentary tract

1.53

0.59

1.1

—

317.46

—

Other disorders of veins

611

1.16

0.59

1.0

1.1

2240.65

339.19

ng/l

0.43

132

Mental and behavioural disorders due to tobacco

114

1.41

0.58

1.1

3227.20

243.23

ng/l

—

Dependent personality disorder

0.00

0.58

0.0

1.1

—

57.00

—

Eating disorders

150

0.67

0.58

1.0

1.1

—

214.50

ng/l

—

Nephropathy related operations

175

1.32

0.58

1.1

190.75

334.77

ng/l

—

Other inflammation of eyelid

175

1.32

0.58

1.2

1.1

131.40

212.22

ng/l

—

Other coagulation defects

1.46

0.58

1.1

32.60

290.05

ng/l

—

Pre-eclampsia or poor fetal growth

454

1.19

0.58

1.0

1.1

323.75

446.73

ng/l

—

Endometriosis ASRM stages 1,2

255

1.26

0.58

1.1

66.60

611.95

ng/l

—

Peripheral retinal degeneration

1.72

0.57

1.0

1.1

—

38.57

ng/l

—

Polycythaemia vera

1.72

0.57

1.3

1.2

—

56.50

—

Other abnormal products of conception

339

1.18

0.57

1.1

85.64

222.95

ng/l

0.55

Calcific aortic valvular stenosis

335

0.79

0.57

1.1

563.33

559.92

ng/l

—

Calcific aortic valvular stenosis, operated

335

0.79

0.57

1.1

563.33

559.92

ng/l

—

Suicide or other Intentional self-harm

383

1.20

0.56

1.1

108.20

514.59

ng/l

—

Operations 2 for CAVS

334

0.79

0.56

1.1

563.33

559.92

ng/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

334

0.79

0.56

1.1

563.33

559.92

ng/l

—

Dislocation, sprain and strain of joint and ligaments of hip

1.62

0.55

1.2

1.1

—

51.57

—

Melanoma in situ

1.62

0.55

1.0

1.1

—

63.29

ng/l

—

Arthropathic psoriasis

159

1.32

0.55

1.0

1.1

1613.20

458.44

ng/l

—

Other skin changes

221

1.27

0.55

1.1

639.00

411.33

ng/l

—

Sulfasalazine

440

1.18

0.54

1.1

848.31

514.72

ng/l

0.25

Other/unspecified enthesopathies, not elsewhere classified

1.42

0.54

1.1

7016.60

419.79

ng/l

—

Redundant prepuce, phimosis and paraphimosis

311

1.22

0.53

1.1

790.29

295.53

ng/l

—

Myocardial infarction

631

0.88

0.53

1.1

389.68

381.33

ng/l

0.01

163

Renal failure

548

1.15

0.52

1.1

277.05

597.88

ng/l

0.85

143

Pedal cyclist injured in other and unspecified transport accidents

143

1.33

0.52

1.2

1.1

23.57

279.24

ng/l

—

Diabetes, insulin treatment (Kela reimbursement)

215

1215

1.08

0.52

1.1

337.96

628.85

ng/l

0.71

270

Injury of muscle and tendon at lower leg level

223

1.26

0.52

1.1

120.13

473.40

ng/l

—

Valvular heart disease excluding rheumatic fever

609

1.13

0.52

1.2

1.1

862.69

727.65

ng/l

0.07

144

Malignant neoplasm of head and neck

0.61

0.51

1.0

1.1

—

288.24

—

Glaucoma

758

1.12

0.51

1.1

1618.67

573.31

ng/l

0.32

186

Other specified/unspecified disorders of bone/cartilage

1.50

0.51

1.0

1.1

—

534.66

—

Melanoma in situ

1.50

0.51

1.0

1.1

—

70.20

ng/l

—

Neonatal jaundice from other and unspecified causes

1.49

0.51

1.2

1.1

—

87.43

—

Schizophrenia or delusion

527

1.16

0.51

1.0

1.1

263.50

422.05

ng/l

0.28

121

Acute alcohol intoxication

388

1.19

0.51

1.1

70.32

408.40

ng/l

—

Other and unspecified vascular occlusions

109

1.38

0.50

1.1

63.20

630.93

ng/l

—

Other diseases of liver

251

1.24

0.50

1.1

104.71

339.11

ng/l

—

Tumor necrosis factor alpha inhibitors

224

1.25

0.50

1.1

310.63

408.82

ng/l

—

Congenital malformations of the urinary system

1.47

0.50

1.1

1.0

314.40

77.30

ng/l

—

Acute and transient psychotic disorders

180

1.28

0.49

1.1

526.17

310.09

ng/l

—

Dental operations, only avohilmo

151

705

1.10

0.49

1.1

386.36

420.28

ng/l

0.06

177

Glucagon-like peptide-1 (GLP-1) analogues

101

744

1.12

0.49

1.1

148.24

834.46

ng/l

1.91

179

Benign neoplasm of other and ill-defined parts of digestive system

225

1.25

0.49

1.1

74.33

450.71

ng/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

298

1.21

0.48

1.1

76.00

394.65

ng/l

—

Major coronary heart disease event

113

835

0.90

0.48

1.1

791.93

706.07

ng/l

0.06

210

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

199

1199

1.08

0.48

1.1

787.15

404.10

ng/l

0.43

270

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

223

0.76

0.48

1.1

—

466.00

—

Pericarditis

1.52

0.48

1.0

1.1

—

412.92

—

Gonarthrosis,primary

176

1019

1.09

0.48

1.1

407.44

668.02

ng/l

0.44

247

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

399

1.16

0.48

1.1

501.63

587.82

ng/l

0.07

Spontaneous rupture of synovium and tendon

1.40

0.48

1.3

1.1

126.40

292.93

ng/l

—

Primary open-angle glaucoma

408

1.17

0.47

1.2

1.1

2259.94

528.38

ng/l

0.39

103

Sequelae of injuries of lower limb

128

1.33

0.47

1.1

—

246.09

—

Fall on same level involving ice and snow

107

966

1.11

0.47

1.0

1.1

1801.50

440.61

ng/l

0.44

232

Pregnancy, childbirth and the puerperium

238

0.83

0.47

1.1

93.22

191.62

ng/l

—

Nasal polyp

263

1.22

0.47

1.1

820.83

350.83

ng/l

—

Female infertility

321

1.15

0.46

1.1

110.09

192.67

ng/l

0.41

Calcific aortic valvular stenosis, including rheumatic fever

335

0.82

0.46

1.1

563.33

553.65

ng/l

—

Seborrhoeic keratosis

291

1.20

0.46

1.1

212.57

409.83

ng/l

—

Seropositive rheumatoid arthritis, strict definition

210

0.76

0.46

1.1

72.20

427.75

ng/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

455

0.86

0.45

1.0

1.1

212.71

553.78

ng/l

—

125

5-aminosalicylic acid

319

1.19

0.45

1.1

150.70

300.48

ng/l

—

Anorexia (incl.atypical)

0.59

0.45

1.0

1.1

—

304.47

ng/l

—

Other gastritis (incl. Duodenitis)

310

1.19

0.45

1.2

1.1

72.57

554.19

ng/l

—

Malignant neoplasm of breast

581

1.12

0.45

1.1

362.83

675.90

ng/l

0.40

125

Delivery

347

0.87

0.45

1.1

220.13

197.78

ng/l

0.06

Other respiratory diseases principally affecting the interstitium

220

0.77

0.44

1.1

710.86

367.28

ng/l

—

Seborrhoeic dermatitis

112

1.34

0.44

1.1

1212.50

282.30

ng/l

—

Other specified/unspecified bacterial intestinal infections

1.40

0.44

1.3

1.1

98.80

137.95

ng/l

—

Suppurative and unspecified otitis media

549

1.13

0.43

1.1

169.00

282.92

ng/l

0.54

108

Acute alcohol intoxication, ICD10

312

1.19

0.43

1.1

78.46

250.24

ng/l

—

Synovial cyst of popliteal space [Baker]

1.41

0.43

1.0

1.1

—

356.36

—

Artificial joint operation, meniscal resection

183

1131

1.08

0.42

1.1

294.80

642.30

ng/l

1.02

265

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

387

1.16

0.42

1.1

434.33

576.35

ng/l

0.15

Non-invasive ventilation

311

1.18

0.42

1.1

147.56

285.32

ng/l

—

Benign neoplasm: Skin of eyelid, including canthus

194

1.24

0.41

1.2

1.1

213.60

248.44

ng/l

—

Mucosal proctocolitis

176

1.25

0.41

1.1

189.13

435.58

ng/l

—

Leisure time condition

258

1.20

0.41

1.0

1.1

1878.33

354.76

ng/l

—

Arterial embolism and thrombosis of lower extremity artery

1.52

0.41

1.0

1.1

—

63.14

—

Benign lipomatous neoplasm

456

0.85

0.41

1.2

1.1

141.88

582.01

ng/l

—

106

Benign neoplasm: Colon, unspecified

303

1.18

0.41

1.1

1211.50

380.80

ng/l

—

Other diseases of oesophagus

114

1.32

0.40

1.1

—

474.58

—

Leiomyoma of uterus

462

1.11

0.40

1.1

196.44

489.11

ng/l

0.38

103

Benign neoplasm: Skin of lower limb, including hip

1.47

0.40

1.0

1.1

—

93.75

—

Crowding of teeth, including avohilmo

114

0.72

0.40

1.2

1.1

20.00

206.14

ng/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.37

0.40

1.0

1.1

—

326.19

ng/l

—

Gout, FINNGEN

352

1.17

0.40

1.0

1.1

621.25

487.26

ng/l

0.13

Injuries to the elbow and forearm

135

1126

1.08

0.39

1.1

101.50

537.49

ng/l

1.86

258

Contraceptive management

552

1.11

0.39

1.1

1015.67

205.20

ng/l

0.76

114

Occupational exposure to risk-factors

1.43

0.39

1.2

1.1

—

708.43

ng/l

—

Fall on and from ladder

106

1.32

0.39

1.0

1.1

56.60

251.40

ng/l

—

Other menopausal disorders

274

0.86

0.38

1.0

1.1

61.11

225.75

ng/l

—

Asthma/COPD (KELA code 203)

201

1329

1.07

0.37

1.1

220.68

548.28

ng/l

1.02

296

Abnormal findings in secretions and smears from cervix uteri vagina vulva

635

1.10

0.37

1.1

44.06

415.67

ng/l

1.53

132

Other maternal disorders predominantly related to pregnancy

110

635

1.09

0.36

1.2

1.1

1658.36

410.52

ng/l

0.35

134

Seropositive rheumatoid arthritis, wide

396

0.86

0.36

1.1

132.58

599.71

ng/l

1.08

DVT of lower extremities

235

1.19

0.36

1.1

196.60

266.66

ng/l

—

Superficial injury of wrist and hand

300

1.17

0.36

1.1

93.70

314.61

ng/l

—

1.42

0.35

1.0

1.1

—

78.50

ng/l

—

Other (not insulin) diabetes medications

199

1128

1.06

0.35

1.1

324.67

635.59

ng/l

0.73

252

Maternal care for known or suspected abnormality of pelvic organs

266

0.86

0.35

1.0

1.1

29.40

291.32

ng/l

—

Malignant neoplasm of breast, HER2-negative

575

1.10

0.35

1.1

378.61

677.62

ng/l

0.37

124

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

126

0.71

0.35

1.1

—

592.27

—

Combinations of oral blood glucose lowering drugs

442

1.13

0.34

1.1

129.74

783.91

ng/l

1.97

105

Kidney transplant status

1.34

0.34

1.1

136.40

301.55

ng/l

—

Glaucoma suspect

509

1.12

0.34

1.2

1.1

122.20

464.01

ng/l

1.54

123

Malignant neoplasm of skin

100

692

1.09

0.33

1.1

531.62

773.71

ng/l

0.25

181

Actinic keratosis

457

1.12

0.33

1.1

1345.00

333.22

ng/l

0.82

120

Maternal care for cervical incompetence

1.31

0.33

1.0

1.1

—

605.73

—

Lichen planus, including avohilmo

247

1.17

0.32

1.1

95.56

385.39

ng/l

—

Pregnancy hypertension

616

1.10

0.31

1.1

207.13

375.81

ng/l

0.36

130

Hyperplasia of prostate

340

1.11

0.31

1.0

1.1

2406.13

329.02

ng/l

1.13

L04AD Calcineurin inhibitors

165

1.21

0.31

1.1

116.14

366.77

ng/l

—

Fracture of forearm

100

866

1.08

0.31

1.0

1.1

79.95

506.27

ng/l

1.40

202

Benign neoplasm: Skin of eyelid, including canthus

202

1.19

0.31

1.2

1.1

213.60

430.00

ng/l

—

289

0.86

0.30

1.1

384.50

565.15

ng/l

—

Multiple myeloma and malignant plasma cell neoplasms

1.30

0.30

1.3

1.1

—

301.07

—

1.29

0.30

1.0

1.1

—

63.60

ng/l

—

Noninflammatory disorders of female genital tract

387

1.09

0.30

1.2

1.1

540.17

187.79

ng/l

0.58

Kela-code for severe mental illness

610

0.90

0.30

1.1

226.29

420.52

ng/l

0.43

140

Other and unspecified disorders of vitreous body

635

1.10

0.30

1.2

1.1

1601.67

717.28

ng/l

0.36

152

Other neurotic disorders

1.27

0.30

1.0

1.1

—

384.56

—

Primary gonarthrosis, bilateral

701

1.09

0.30

1.1

104.67

836.69

ng/l

2.08

174

Normotensive glaucoma

1.29

0.30

1.5

1.1

107.67

562.83

ng/l

—

In situ neoplasms

505

1.11

0.29

1.1

644.56

597.50

ng/l

—

119

Bacterial pneumonia, not elsewhere classified

502

0.90

0.29

1.1

114.80

273.40

ng/l

1.20

115

Other/unspecified seropositive rheumatoid arthritis

388

0.88

0.29

1.1

132.58

599.71

ng/l

1.08

L02BA Anti-estrogens

222

1.17

0.29

1.2

1.1

54.71

834.61

ng/l

—

Gout, strict definition

217

0.83

0.29

1.1

1387.00

757.70

ng/l

—

Myocardial infarction, without ST-elevation

484

1.11

0.29

1.1

525.33

630.26

ng/l

0.13

134

Postpartum care and examination

139

0.83

0.29

1.3

1.1

112.00

80.64

ng/l

—

Type 2 diabetes, definitions combined

195

1103

1.05

0.29

1.1

371.47

642.20

ng/l

0.58

245

Haemorrhage in early pregnancy

429

1.11

0.28

1.1

3221.18

489.89

ng/l

0.39

Conduction disorders

373

1.11

0.28

1.1

1481.36

398.34

ng/l

0.36

Benign leiomyoma with endometriosis

204

1.18

0.28

1.1

96.20

231.30

ng/l

—

Dental caries 1 and operation codes, only avohilmo

280

0.90

0.28

1.1

589.68

1055.09

ng/l

0.30

L04AC Interleukin inhibitors

1.29

0.28

1.1

—

354.80

—

Aortic aneurysm

293

1.14

0.28

1.1

22.24

585.95

ng/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

386

0.88

0.27

1.1

132.58

599.71

ng/l

1.08

Long labour

328

0.88

0.27

1.0

1.1

23.20

551.86

ng/l

—

Skin changes due to chronic exposure to nonionizing radiation

471

1.10

0.27

1.1

1257.73

326.04

ng/l

0.80

124

194

1.17

0.27

1.1

418.56

772.52

ng/l

—

Peripheral artery disease

496

0.91

0.27

1.1

168.50

667.09

ng/l

—

142

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

680

1.08

0.27

1.1

207.13

373.40

ng/l

0.38

141

Sulfonylureas

408

0.90

0.26

1.0

1.1

152.00

519.25

ng/l

1.21

105

Benign neoplasm of other and ill-defined parts of digestive system

243

1.15

0.26

1.1

74.33

469.16

ng/l

—

Bacterial pneumonia (organism specified)

617

0.91

0.26

1.1

120.53

378.99

ng/l

1.34

145

Myocardial infarction, with ST-elevation

225

0.84

0.26

1.1

643.41

500.75

ng/l

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

470

1.08

0.26

1.1

324.17

517.71

ng/l

0.20

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

470

1.08

0.26

1.1

324.17

517.71

ng/l

0.20

Single delivery by forceps and vacuum extractor

119

1.18

0.26

1.2

1.1

115.20

211.79

ng/l

—

Biguanides

194

1138

1.05

0.26

1.1

340.70

634.53

ng/l

0.66

259

Labour and delivery complicated by fetal stress [distress]

238

1.12

0.25

1.2

1.1

132.00

177.03

ng/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

282

1.10

0.25

1.1

504.50

696.49

ng/l

0.19

Endovascular or surgical operations to intracerebral aneurysms

1.20

0.25

1.0

1.1

—

571.35

—

499

1.09

0.25

1.1

1385.38

321.44

ng/l

1.02

126

Other malignant neoplasms of skin (=non-melanoma skin cancer)

624

1.08

0.24

1.1

616.95

624.92

ng/l

0.01

158

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

230

0.85

0.24

1.1

35.14

204.33

ng/l

—

In situ neoplasms

488

1.09

0.24

1.1

644.56

605.66

ng/l

—

111

Non-ischemic cardiomyopathy

374

0.90

0.24

1.0

1.1

69.99

273.37

ng/l

1.77

Acute pancreatitis

287

0.87

0.24

1.1

1164.00

507.87

ng/l

—

Glucosamine medication

616

1.08

0.24

1.1

2324.79

381.15

ng/l

0.51

147

Persons encountering health services for specific procedures, not carried out

1.27

0.24

1.0

1.1

—

237.09

—

Emphysema

0.71

0.24

1.0

1.1

—

259.48

—

Malignant neoplasm of breast, HER-positive

506

1.09

0.23

1.1

501.62

750.85

ng/l

0.24

110

Benign neoplasm: Skin of lower limb, including hip

1.28

0.23

1.0

1.1

—

55.38

—

Benign leiomyoma with endometriosis

209

1.15

0.22

1.1

96.20

247.62

ng/l

—

Delayed milestone in childhood

1.26

0.22

1.0

1.1

—

43.67

—

Other embolism and thrombosis

157

0.83

0.22

1.0

1.1

—

330.62

—

Major coronary heart disease event excluding revascularizations

106

776

0.94

0.22

1.1

877.40

642.01

ng/l

0.16

194

Ulcerative colitis (strict definition, require KELA)

257

1.13

0.22

1.2

1.1

149.90

355.34

ng/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.21

0.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

194

1110

1.04

0.21

1.1

357.84

643.65

ng/l

0.63

248

Bacterial pneumoniae

537

0.92

0.21

1.1

128.18

257.35

ng/l

0.99

125

Acute pancreatitis (for exclusion)

283

0.88

0.21

1.1

1164.00

407.09

ng/l

—

Embedded and impacted teeth

341

1.10

0.21

1.1

311.00

147.23

ng/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.16

0.21

1.0

—

40.17

—

Supervision of high-risk pregnancy

197

0.89

0.21

1.0

1.1

616.83

100.85

ng/l

—

Personal history of allergy to drugs, medicaments and biological substances

0.00

0.21

0.0

1.1

—

Maternal care for other known or suspected fetal problems

229

0.90

0.21

1.1

83.38

173.93

ng/l

—

Persons encountering health services in circumstances related to reproduction

118

758

1.06

0.20

1.1

1590.24

229.32

ng/l

0.84

154

Parodontitis or/and operation codes

118

739

0.95

0.20

1.1

1030.57

838.59

ng/l

0.10

152

Injuries to the hip and thigh

616

1.07

0.20

1.1

1000.79

491.47

ng/l

0.44

142

Varicose veins

112

803

1.05

0.19

1.1

341.59

326.39

ng/l

0.02

177

Mixed conductive and sensorineural hearing loss

146

1.16

0.19

1.1

47.38

548.18

ng/l

—

Benign lipomatous neoplasm

426

0.92

0.18

1.2

1.1

141.88

323.41

ng/l

—

Abrasion of teeth

321

0.92

0.18

1.2

1.1

769.00

951.95

ng/l

—

Nontoxic goitre/thyroid nodule

436

0.92

0.18

1.1

319.23

834.15

ng/l

0.60

100

Toxic effect of contact with venomous animals

1.21

0.18

1.1

—

410.46

—

Nontoxic multinodular goitre

242

1.12

0.18

1.1

459.17

682.90

ng/l

—

Impacted maxillary molar

1.19

0.18

1.0

1.1

—

370.60

—

Fracture of shoulder and upper arm

502

1.08

0.18

1.1

98.64

433.36

ng/l

1.09

121

Procreative management

497

1.07

0.18

1.1

434.00

233.55

ng/l

0.31

Ankylosing spondylitis, strict definition

1.17

0.17

1.1

—

411.26

—

Struck by thrown, projected or falling objec

1.17

0.17

1.3

1.1

—

463.99

—

malignant neoplasm of female genital organs

174

0.86

0.17

1.0

1.1

28.67

382.43

ng/l

—

Ulcerative colitis

387

1.09

0.17

1.1

120.79

338.15

ng/l

1.01

Spontaneous abortion

534

0.94

0.17

1.1

159.06

529.49

ng/l

0.61

115

Vascular disorders of the intestines

0.75

0.17

1.2

1.1

—

470.88

—

L01XE Protein kinase inhibitors

0.73

0.17

1.0

1.1

—

547.55

—

Cutaneous abscess, furuncle and carbuncle

388

1.08

0.16

1.1

61.55

264.90

ng/l

1.70

Type 2 diabetes, definitions combined, including avohilmo

194

1110

1.03

0.16

1.1

481.68

624.19

ng/l

0.24

246

Deep bite

163

1.13

0.16

1.1

32.33

213.92

ng/l

—

Complications of labour and delivery

117

624

1.05

0.16

1.1

1553.89

375.97

ng/l

0.43

129

Pregnancy examination and test

152

1.11

0.16

1.3

1.1

41.11

94.70

ng/l

—

Malignant neoplasm of breast, HER-negative

273

1.10

0.16

1.1

97.43

298.70

ng/l

—

Malignant melanoma

187

1.12

0.15

1.1

88.80

482.06

ng/l

—

Disorders of breast

740

1.05

0.15

1.1

418.58

546.33

ng/l

0.13

165

Umbilical hernia

409

1.08

0.15

1.0

1.1

95.91

558.77

ng/l

1.66

100

Parodontitis and operation codes

166

1246

1.04

0.15

1.1

728.57

556.69

ng/l

0.14

289

Idiopathic gout

119

0.84

0.15

1.0

1.1

88.00

411.85

ng/l

—

Heart failure, not strict

134

960

0.96

0.15

1.1

642.19

669.30

ng/l

0.02

227

Dermatographic urticaria

1.14

0.15

1.0

1.1

—

126.47

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

102

1.18

0.15

1.0

1.1

18.20

296.25

ng/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

304

1.09

0.14

1.1

92.57

667.00

ng/l

—

Presence of cardiac and vascular implants and grafts

503

0.95

0.13

1.1

1215.27

504.72

ng/l

0.41

122

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

451

1.06

0.13

1.1

388.13

488.34

ng/l

—

103

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

270

1.07

0.13

1.1

538.13

669.02

ng/l

0.12

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

312

1.08

0.13

1.1

78.44

701.67

ng/l

—

Abnormal serum enzyme levels

417

1.07

0.13

1.1

206.42

752.81

ng/l

1.64

115

Pedestrian injured in transport accident

1.18

0.12

1.2

1.1

—

280.85

—

Unstable angina pectoris

464

0.95

0.12

1.1

1360.08

543.60

ng/l

0.28

128

Heart failure and antihypertensive medication

247

1.07

0.12

1.0

1.1

417.39

276.67

ng/l

—

Coxarthrosis, primary, with hip surgery

636

0.95

0.12

1.1

46.07

797.97

ng/l

2.25

167

Gout, idiopatic and unspecified

317

1.07

0.12

1.1

621.25

588.01

ng/l

0.03

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

249

1.08

0.11

1.2

1.1

149.90

355.34

ng/l

—

Malignant melanoma of skin

143

1.12

0.11

1.2

1.1

88.80

436.55

ng/l

—

Degeneration of macula and posterior pole

519

0.95

0.11

1.1

266.89

793.39

ng/l

0.94

127

Hallux valgus (acquired)

385

1.05

0.11

1.1

353.15

724.62

ng/l

0.55

Type of accident

437

1.05

0.10

1.0

1.1

1694.30

328.18

ng/l

—

Acute renal failure

261

1.07

0.10

1.1

74.00

674.48

ng/l

—

Mental retardation, excluding more controls

1.12

0.10

1.0

1.1

—

516.22

—

Single delivery by caesarean section

156

0.93

0.10

1.2

1.1

4185.80

195.00

ng/l

—

Hepatic failure, not elsewhere classified

1.09

0.09

1.4

1.1

—

369.29

—

Ulcerative colitis, NAS

203

1.08

0.09

1.3

1.1

178.63

399.61

ng/l

—

Chronic periodontitis

203

1.08

0.09

1.0

1.1

261.71

341.49

ng/l

—

Non-allergic asthma

116

1.12

0.09

1.0

1.1

—

449.31

—

Female infertility, cervigal, vaginal, other or unspecified origin

306

1.05

0.09

1.1

173.00

194.57

ng/l

—

Unspecified mental disorder

694

1.04

0.09

1.0

1.1

212.20

386.84

ng/l

0.43

159

Parodontitis or operation codes

175

1261

1.02

0.09

1.1

728.57

572.22

ng/l

0.13

293

malignant neoplasm of male genital organs

372

1.04

0.08

1.1

410.62

780.76

ng/l

0.56

Benign neoplasm: Colon, unspecified

341

1.06

0.08

1.1

1211.50

563.22

ng/l

—

Other obstetric trauma

1.05

0.08

1.0

1.1

—

444.80

ng/l

—

Arterial embolism and thrombosis

1.05

0.08

1.0

1.1

—

122.77

—

Obstructed labour due to maternal pelvic abnormality

216

0.93

0.08

1.2

1.1

136.00

797.93

ng/l

—

Anomalies of dental arch relationship, including avohilmo

295

0.94

0.08

1.2

1.1

115.78

324.65

ng/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

524

1.03

0.08

1.0

1.1

682.60

753.48

ng/l

0.05

124

Mental retardation

0.83

0.08

1.0

1.1

—

394.58

—

Delivery, wide proxy

278

0.96

0.08

1.1

235.38

209.17

ng/l

0.06

Intestinal stricture

420

1.05

0.08

1.1

303.90

489.33

ng/l

—

109

Open bite

0.78

0.08

1.4

1.1

—

58.00

—

Olecranon bursitis

0.77

0.08

1.0

1.1

—

293.21

—

Laparoscopic right hemicolectomy

1.09

0.08

1.1

—

462.52

—

Papillary adenocarcinoma of thyroid gland

1.09

0.08

1.0

1.1

—

469.93

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

1.04

0.08

1.0

1.1

—

159.87

ng/l

—

Medicines for HER+ breast cancer

535

1.04

0.07

1.1

501.62

727.78

ng/l

0.22

114

Gonarthrosis, primary, with knee surgery

731

0.97

0.07

1.0

1.1

238.38

796.74

ng/l

1.20

185

Acute peritonitis

1.08

0.07

1.0

1.1

—

230.05

—

Effects of foreign body entering through natural orifice

392

1.05

0.07

1.1

179.20

296.92

ng/l

—

Obesity, other/unspecified

539

0.96

0.07

1.0

1.1

384.22

476.73

ng/l

—

114

Ulcerative colitis (strict definition, all Crohn cases excluded)

214

0.93

0.07

1.2

1.1

207.43

371.41

ng/l

—

False labour

296

1.04

0.07

1.0

1.1

84.75

210.02

ng/l

—

Pregnancy with abortive outcome

120

614

1.02

0.06

1.1

878.03

474.79

ng/l

0.22

131

Maternal care related to the fetus and amniotic cavity and possible delivery problems

454

0.97

0.06

1.1

1952.64

283.55

ng/l

0.40

Parodontitis

174

1262

1.02

0.06

1.1

728.57

572.22

ng/l

0.13

293

Complications predominantly related to the puerperium

386

1.04

0.05

1.2

1.1

283.80

496.23

ng/l

—

Contact with and exposure to communicable diseases

523

0.97

0.05

1.1

123.25

413.19

ng/l

—

106

Postpartum hemorraghe, all women as controls

365

1.04

0.05

1.1

119.60

435.43

ng/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

476

1.03

0.04

1.0

1.1

1694.30

308.44

ng/l

—

106

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

201

0.95

0.04

1.1

46.80

440.16

ng/l

—

Malignant neoplasm of corpus uteri

1.10

0.04

1.0

1.1

18.20

433.25

ng/l

—

COPD (mode)

323

1.03

0.04

1.1

161.43

375.27

ng/l

0.77

Inguinal hernia

110

730

1.02

0.04

1.1

1098.39

451.95

ng/l

0.45

176

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

121

1.07

0.03

1.2

1.1

—

471.35

—

Postpartum hemorraghe, parous women as controls

343

0.97

0.03

1.1

119.60

439.28

ng/l

—

Postmenopausal atrophic vaginitis

242

0.97

0.03

1.2

1.1

357.31

248.77

ng/l

0.15

Basal cell carcinoma

658

1.02

0.03

1.1

679.15

672.74

ng/l

0.00

172

Hernia of abdominal wall

727

1.02

0.03

1.0

1.1

348.33

666.61

ng/l

0.52

180

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

290

1.03

0.03

1.2

1.1

142.82

329.69

ng/l

0.63

D07AA Corticosteroids, weak (group I)

239

0.96

0.03

1.2

1.1

113.80

396.90

ng/l

—

Familial hypercholesterolemia, with ischemic heart disease

122

1.07

0.02

1.2

1.1

36.40

445.71

ng/l

—

Gestational [pregnancy-induced] hypertension

379

0.97

0.02

1.2

1.1

62.63

500.43

ng/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

252

1.03

0.02

1.0

1.1

396.20

451.74

ng/l

—

Psoriasis vulgaris

281

1.03

0.02

1.0

1.1

907.44

433.77

ng/l

—

Postpartum haemorrhage

339

0.98

0.02

1.1

119.60

565.76

ng/l

—

Dental caries 3 and operation codes, only avohilmo

326

1.02

0.02

1.1

519.64

937.43

ng/l

0.33

Leiomyoma of uterus

112

630

1.01

0.02

1.1

153.54

621.30

ng/l

0.96

146

Alcohol dependence

429

0.98

0.02

1.2

1.1

38.40

402.90

ng/l

—

106

Diabetes mellitus in pregnancy

318

1.02

0.02

1.2

1.1

88.10

538.45

ng/l

—

Gout, unspecified

262

1.03

0.02

1.1

880.13

691.71

ng/l

—

Overexertion and strenuous or repetitive movements

137

0.95

0.01

1.2

1.1

86.40

244.38

ng/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

505

1.01

0.01

1.0

1.1

751.61

763.97

ng/l

0.01

122

Chronic periodontitis, including avohilmo

170

1262

1.00

0.00

1.1

728.57

575.95

ng/l

0.12

291

Basal cell carcinoma, including avohilmo

670

1.00

0.00

1.1

679.15

650.74

ng/l

0.02

178

Otitis media, unspecified

166

1.00

0.00

1.1

97.80

227.84

ng/l

—

Other appendicitis

115

0.96

0.00

1.0

1.1

—

280.30

—

Obstructed labour due to malposition and malpresentation of fetus

332

0.99

0.00

1.1

684.33

498.49

ng/l

—

Early onset COPD

325

1.02

0.00

1.2

1.1

119.58

437.81

ng/l

—

Primary coxarthrosis, bilateral

385

0.99

0.00

1.1

2277.00

547.35

ng/l

—

L02BG Aromatase inhibitors

435

0.99

0.00

1.1

568.29

801.81

ng/l

0.20

101

Other arthrosis

626

0.99

0.00

1.1

171.88

538.18

ng/l

—

161

Seropositive rheumatoid arthritis

337

1.01

0.00

1.1

132.58

1104.48

ng/l

1.20

Impacted teeth

260

1.00

0.00

1.1

28.83

180.55

ng/l

—

Ventral hernia

331

1.00

0.00

1.0

1.1

845.40

502.41

ng/l

—

Malignant neoplasm of prostate

361

1.00

0.00

1.1

449.74

796.87

ng/l

0.48

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

516

1.00

0.00

1.1

751.61

763.97

ng/l

0.01

122

Presbycusis

113

0.97

0.00

1.1

—

552.52

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.0

1.1

—

Benign neoplasm: Testis

0.00

0.0

1.2

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.0

1.2

—

Enterobiasis

0.00

0.0

1.0

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.0

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.2

—

Thoracic root disorders

0.00

0.0

1.0

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.2

—

Benign neoplasm: Scrotum

0.00

0.0

1.2

—

Cleft lip

0.00

0.0

1.0

—

Benign neoplasm: Epididymis

0.00

0.0

1.2

—

Benign neoplasm: Testis

0.00

0.0

1.2

—

Dacryoadenitis

0.00

0.0

1.0

—

Placental disorders

0.00

0.0

1.0

—

Lung transplantation

0.00

0.0

1.0

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.00

0.00

1.0

1.1

—

578.15

ng/l

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

ILD medications: pirfenidone

0.00

0.0

1.1

—

Alcoholic cardiomyopathy

0.00

0.0

1.2

—

Lung transplant status

0.00

0.0

1.0

—

0.00

0.0

1.2

—

Burn and corrosion, body region unspecified

0.00

0.0

1.1

—

Epileptic seizures related to alcohol

0.00

0.0

1.1

—

Carcinoma in situ of skin

0.90

0.00

1.0

1.1

—

392.48

ng/l

—

Non-small cell lung cancer, adenocarcinoma

1.00

0.00

1.0

1.1

—

578.15

ng/l

—

Other and unspecified nonscarring hair loss

0.00

0.0

1.0

—

Mitochondrial myopathy

0.00

0.0

1.0

—

Acanthosis nigricans

0.00

0.0

1.2

—

Etanercept

0.93

0.00

1.1

—

279.64

—

Cicatricial alopecia [scarring hair loss]

0.00

0.0

1.1

—

Pityriasis rosea

0.00

0.0

1.1

—

Cyst of spleen

0.00

0.0

1.0

—

Benign neoplasm: Scrotum

0.00

0.0

1.1

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

Benign neoplasm: Endocrine pancreas

0.00

0.0

1.2

—

Effects of air pressure and water pressure

0.00

0.0

1.1

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.0

1.2

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.0

1.0

—

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS